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RTTCP Regional Tsetse and Trypanosomiasis Control Programme
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SRD Slow Release Device
TMB 3,3',5,5' tetramethylbenzidine
STATISTICS
The Student “t” test for paired samples and Analysis of variance (Anova) were used to 
determine any variation and differences between the two groups. Values of P < 0.05 
were considered significant. These tests were conducted using Excel and Minitab 
computer programmes.
Summary
This thesis describes studies to improve the ELISA method for determining the 
concentrations of isometamidium and homidium in the serum of treated animals, and the 
use of the improved ELISA to monitor drug levels in the field and laboratory.
Chapter One is a general review of the relevant literature.
Chapter Two describes experiments that were conducted to improve the competitive 
enzyme immunoassay for the detection of isometamidium in the sera of treated animals. 
Improvements were required to this assay to reduce inter-sample variation of sera 
obtained from untreated animals. The use of a new conjugate isometamidium- 
horseradish-peroxidase produced using the n-hydroxysuccinamide-carbodiimide linkage 
and modifications to the assay to a sequential saturation competitive enzyme assay, 
successfully solved the problem of intersample variation. Following the successfull 
modifications to the isometamidium detection ELISA similar improvements were made 
to the homidium detection ELISA.
Chapter Three describes the use of the new competitive enzyme immunoassay to 
measure the concentrations of isometamidium in the sera of 35 treated cattle reared 
under traditional management in a field situation in Zambia. Breakthrough trypanosome 
infections in the individual cattle were monitored and related to the isometamidium 
concentration levels at the time of trypanosome detection. One of the 10 breakthrough 
infections occurred when relatively high drug levels were present and this was taken to 
indicate that the breakthrough infection may have been drug resistant. The work in this
section showed that trypanocide detection ELISAs are a useful tool for determining the 
drug levels in individual cattle sera and can provide indirect evidence of drug resistant 
trypanosomes when used in combination with parasitological monitoring methods.
Chapter Four describes the evaluation of the prophylactic effect of a slow release device 
(SRD) containing homidium bromide. The prophylatic effect of this SRD was compared 
with that of the normal intramuscular (i.m.) injections of isometamidium and homidium 
bromide. In the SRD group 50 % of the cattle remained protected up to the fourth 
month after treatment. In the i.m. isometamidium group 50 % of the cattle were 
protected up to the third month after treatment whereas in the i.m. homidium 50 % 
remained protected only up to the second month. The levels of isometamidium and 
ethidium in the serum reflected these differences in the period of prophylaxis.
Chapter Five describes an experiment to investigate influence of nutrient intake on the 
duration of isometamidium prophylaxis in sheep. In this experiment groups of sheep on 
two planes of nutrition were injected with isometamidium (0.5 mg/kg) and then 
challenged monthly with bloodstream forms of T. congolense by subcutaneous injection. 
The concentration of isometamidium in the sera of the animals declined at a similar rate 
in both groups and was below the lower limit of detection at the time of the 
breakthrough infections. The mean body weight and serum albumin levels of the animals 
on the high plane diet was significantly higher than those of the animals on the low plane 
diet throughout the experiment period. However the mean periods of prophylaxis were 
very similar in the high plane and low plane diet groups (121 ± 14 days and 117 ± 11 
days respectively).
C hap ter 1 
General introduction and literature review
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African Animal Trypanosomiasis 
Introduction
Trypanosomiasis is a debilitating and commonly fatal disease of domestic cattle and small 
ruminants. It occurs in tropical and sub-tropical regions and is caused by infection with 
the protozoan parasites known as trypanosomes. In sub-Saharan Africa, the disease is 
spread mainly by the bite of trypanosome-infected tsetse flies. Trypanosomiasis is 
considered the most important infectious disease holding back the development of 
livestock production in much of Africa (ILRAD reports, April 1993).
Parasites
Trypanosomiasis is caused by protozoan parasites which are members of the Order 
Kinetoplastida, Family Trypanosomatidae and Genus Trypanosoma. On the basis of the 
site of development of the organism in the insect vector that transmits them, the genus is 
subdivided into two sections, the Stercoraria and Salivaria. Trypanosomes (e.g. T. 
theileri) in the Stercoraria section develop (from epimastigotes to infective 
metatrypanosomes) in the hindgut of the vector following ingestion of a blood meal 
contaminated with parasites, and infection is transmitted to the host by faecal 
contamination. Salivarian trypanosomes (T. vivax, T. congolense, T. brucei brucei) 
develop in the mouth parts of the tsetse fly (Glossina species) and are transmitted from 
host to host by inoculation when a fly is having a bloodmeal. In the Salivarian section 
there are some species that can be mechanically transmitted in the mouth parts of biting 
Diptera and other arthropods (Leach and Roberts, 1981).
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The trypanosomiasis affecting livestock in Africa is mainly caused by Trypanosoma 
congolense, T. brucei species and T. vivax. These species of trypanosomes can be 
differentiated on the basis of their morphology on stained preparations viewed by the 
light microscope. Stained preparations reveal their general appearance (e.g. size, shape, 
flagellum, undulating membrane) and some essential internal structures (e.g. nucleus, 
kinetoplast, basal body) that can be used for speciation (Table 1.1).
Table 1.1 Morphological structure of pathogenic trypanosomes. 
(Ref: Mulligan 1970; Hopkins, 1995)
Species Size Flagellum Undulating
Membrane
Shape of 
posterior 
end
Size of 
Kinetoplast
Position of 
Kinetoplast
T. brucei 11-39 ja in slender 
form free 
flagellum
developed bluntly
pointed
small subterminal
and
marginal
T. congolense 8- 24 p no free 
flagellum
not
developed
round medium marginal
and
subterminal
T. vivax 18-31 p free
flagellum
slightly
developed
swollen and 
round
large terminal
Trypanosomes can also be speciated in wet smears based on their movement. T. vivax 
moves fast across the field, T. brucei moves within a field in a circular manner and T. 
congolense normally adheres to red blood cells and moves sluggishly.
Based on the distribution in the host, Losos and Ikede (1972) divided the tsetse- 
transmitted trypanosomes into two groups;
i) Haematic group: these confine themselves to the blood and lymphatic systems. These 
include T. vivax and T. congolense.
ii) Humoral group: those that also invade connective tissue and body cavities. This group 
include T. brucei species.
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T. congolense in the early stages of infection is capable of developing outside the 
circulatory system (Roberts et al., 1969; Luckins and Gray, 1978; 1979).
The distinction of trypanosomes into the above two groups is important for two reasons.
(i) The distribution of trypanosomes in the animal body leads to differences in their 
susceptibility to drugs (Williamson, 1976); hence identification of the trypanosome 
species is important for the correct choice of drug treatment.
(ii) In addition to signs like cachexia and anaemia, tissue damage is also a feature of 
infections from trypanosomes belonging to the subgenus Trypanozoon.
Vectors
Tsetse flies (Genus Glossina) are found only in sub-Saharan African and infest almost 
10 million Km2 of the continent. The genus Glossina consists of 23 species within which 
three main groups of tsetse are recognised on the basis of their preference for habitat. 
The groups are: the riverine (palpalis group); the forest (fusca group); and the savannah 
(morsitans group).
The palpalis group consists of Glossina fuscipes fuscipes, G. f  martinii and G. /. 
quanzensis (Mulligan, 1970). G. palpalis occupies the Congo basin, the basin of the 
upper Nile and rivers of West Africa.
The fusca group may be divided into three sub-groups. The first sub-group include: 
Glossina tabaniformis, G. haningtoni and G. nashi. These are confined to the Congo 
basin and the forests of Gabon, southern Cameroon and the Guinea coast as far west as 
Liberia. The second sub-group are distributed peripherally around the fly-belts of the
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forest group include G. fusca, G. me dicorum, G. fuscipleuris and G. schwetzi. The third 
sub-group include G. longipennis and G. brevipalpis.
The morsitans group include Glossina morsitans morsitans and Glossina m. 
submorsitans. They are found in the deciduous woodland and savannah vegetations 
forming a band around the rain forest of the Congo basin and the Guinea coast in West 
Africa (Mulligan, 1970).
The groupings simply reflect the need that all tsetse have for a humid environment and 
protective shade from sunlight, which the leafy vegetation provides. The arid, treeless 
lands limit tsetse distribution to the north, and the cool climate of increasing latitude 
limits the southern distribution of the fly (Connor, 1989)
The limit of the tsetse fly distribution on the northern part of the continent is the Sahara 
desert (15°N) and on the southern part the Kalahari desert (29°S), Natal and the tropical 
highlands. The individual species distribution within the flybelt is also affected by climatic 
factors. Climatic factors such as temperature and rainfall determines the type of 
vegetation to be found in the area. The optimal temperatures for tsetse are around 25°C. 
Sub-zero temperatures and temperatures of about 46°C will result in the death of the fly 
(Mulligan, 1970).
Tsetse feed exclusively on blood and transmit the parasites from one host to another 
during feeding. Parasites undergo a cycle of development and maturation before 
inoculation into a vertebrate host. If transmission is carried in this way it is called cyclical
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transmission. If the hungry fly is interrupted when having a meal of blood, live 
trypanosomes in the blood present on the fly’s mouthparts can be inoculated into a 
second animal as the fly completes its meal. In this case it is not cyclical transmission but 
mechanical because no development of the parasites has taken place in the fly. Tabanid 
flies transmit the parasites by mechanical transmission and no cycle of trypanosome 
development takes place in these flies.
The methods used for sampling of tsetse flies include:
1. Reconnaissance e.g. Black screen man fly rounds.
2. Traps.
3. Searches for resting flies.
4. Searches for puparia
1. A black screen man fly round involves two men carrying a ‘screen’ usually a piece of 
black cotton cloth, rectangular in shape and about 1.2 meters x 0.6 meters, attached 
along one of its long sides to a pole which is carried between the two men on their 
shoulders. The black cloth is baited with attractants such as acetone and phenols. The 
men walk along marked fly round routes and stop at frequent intervals, look about and 
catch any flies that land on the screen and in their vicinity with a hand-net.
Screens can also be mounted on a vehicle or a bicycle. In the case of a bicycle a screen 
about 0.6 meters square is hung behind the back wheel. This is covered with banding 
grease or other suitable slow-drying sticky substance. The bicycle is ridden through 
suspected areas, after which tsetse may be found stuck to the screen.
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The species usually detected by this method are the palpalis group, morsitan group (G. 
morsitans and G. swynnertoni) and the fusca group (G. brevipalpis, G. fuscipleuris and 
G. longipennis). Males are more attracted to moving objects and therefore are caught 
more often in fly rounds. It seems their attraction to moving objects brings them into 
contact with teneral females which are also attracted to moving objects in search of food.
2. Traps are mainly used for studying in detail the distribution and abundance of tsetse 
flies. Like the black screen they are baited with attractants. They have been used in 
surveys for G. pallidipes and G. palpalis. The main advantage of this method is that 
once in position, traps will be at work throughout the hours of daylight, seven days a 
week. The other advantage is that they have demonstrated the presence of tsetse when 
other methods have failed.
Traps are devices into which tsetse flies are attracted and caught. They consists of 
attractants and a cage designed in such a way that the fly can easily enter but not escape. 
The first such design was the Harris trap by which very large numbers of G. pallidipies 
were caught in Zululand.
3. Another method used for sampling is to search for flies in their resting sites such as 
crevices in the bark of big trees, root holes and thickets.
4. Surveys for puparia involves searching the soil in suitable breeding sites by hand. 
Phelps et al. (1966), attempted to improve yields of puparia by the use of sieves, which 
proved useful in scooping soil from animal burrows. Another method used by Abedi and 
Miller (1963), was flotation in water since puparia float to the surface.
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Hosts
Trypanosomses are found throughout the world and parasitise fishes, amphibia, reptiles, 
birds and mammals (Connor, 1989). Table 1.2 below shows the list of the vertebrate 
hosts of the Salivarian trypanosomes and the mode of transmission (Leach and Roberts, 
1981).
Table 1.2 Distribution, Vertebrate Hosts and Mode of Transmission of Salivarian 
Trypanosomes. (After Leach and Roberts, 1981)
Subgenus Species Geographical
distribution
Vertebrate
host
Transmission
cyclical non-cyclical
Duttonella T. vivax - West, 
Central and 
East Africa
- West Indies, 
S. America
- Wild and
domestic
ungulates
- Glossina
- none
- biting 
Diptera
- biting 
Diptera
Nannomonas T. congolense 
T. simiae
-West, 
Central, and 
East Africa 
- West, 
Central and 
East Africa
- Ungulates 
and carnivores
- Mainly Suids
- Glossina
- Glossina
- biting 
Diptera (rare)
- biting 
Diptera
Pyonomonas T. suis Central Africa Suids Glossina not known
Trypanozoon T. brucei 
T. evansi
T. equiperdum
- West,
Central and 
East Africa
- North Africa.
- Asia, Central 
and South 
America
- North and 
South Africa, 
Asia, South 
America
- Carnivores 
(some strains 
infective to 
man)
- Ungulates 
and carnivores
- Carnivores
- Equines
- Glossina
- none
- none
- none
- biting 
Diptera (very 
rare)
- biting 
Diptera
- biting 
Diptera
- coitus
Disease
Animal trypanosomiasis is generally known by three names;
i) Nagana in Africa south of the Sahara.
ii) Surra, caused by T. evansi in North Africa and Asia.
iii) Dourine, caused by T. equiperdum
In wild animals, such as warthog, bushbuck, kudu or buffalo, trypanosomes become 
established but do not produce disease. This is because these animals and the parasite 
have evolved together for many years so that a balanced relationship exists. These 
species remain as reservoirs of the parasite. In domestic animals the host/parasite 
relationship has not fully developed because they are relative newcomers to the tsetse- 
infested areas. Among domesticated animals, humpless cattle (e.g. N’dama of West 
Africa) of Bos taurus types were the first to be introduced into northern and western 
Africa from about 4500 BC onwards, hence they are better adapted to tsetse-transmitted 
trypanosomes. N’dama cattle will tolerate trypanosomes without showing obvious signs 
of the disease as long as they are not stressed by factors such as poor nutrition, working, 
lactation, parturition or other diseases. Humped Zebu (Bos indicus) types were 
introduced some 3000 years later than Bos taurus and reached Central and Southern 
Africa around 700 A.D. Goats and sheep were introduced at the same time as Bos 
indicus. In these animals the host/parasite relationship has not fully developed and these 
species will develop clinical disease when they are infected with parasites (Connor, 
1989).
The course of the disease is variable depending on the factors associated with the host 
and the parasites. Generally it is characterised by the intermittent presence of parasites in
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the blood and intermittent fever. The course of the infection may be acute, sub-acute or 
chronic. In acute cases, animals develop anaemia rapidly and lose weight and body 
condition over a few weeks. They may die if not treated. Sub-acute or chronic 
trypanosomiasis runs a course of several months to one year or longer. The common sign 
of infection during this form, is progressive emaciation, poor general condition, 
lymphnode enlargement, anaemia and weakness. Animals may die or recover on their 
own (self-cure).
Mammalian hosts may posses natural resistance to particular species of trypanosomes. 
Pigs are refractory to infection with T. vivax (Stephen, 1966) and cattle are not likely to 
be infected with T. simiae (Roberts, 1971).
The pathology of trypanosomiasis is primarily the result of anaemia, immunological 
disturbance and generalised tissue damage, which produce different effects in mature and 
immature animals (Table 1.3).
Table 1.3 Effect of trypanosomiasis in mature and immature animals. 
(Connor, 1989).
Effects
Breeding male Semen quality and libido reduced.
Working Ox Draught power reduced.
Breeding female - Oestrus cycles become irregular.
- Abortion is common.
- Birth weights are low and calves sickly.
- Weak calves result in higher neonatal mortality rates.
Young stock - Growth rates are reduced.
- Frequently stunted
- More vulnerable to other diseases.
- General failure to thrive.
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There are indications that young animals may be less susceptible to trypanosomiasis than 
adults (Fiennes et al., 1946).
Diagnosis
The tests used for diagnosing African animal trypanosomiasis are generally put into two 
categories (Table 1.4); direct and indirect tests. Direct tests depend upon the 
demonstration of the trypanosomes in the peripheral blood or lymph. Indirect tests 
identify the product of the trypanosomes or antibody produced by the host as a specific 
response to the presence of the parasite or its by-products. Indirect methods are of value 
if the parasites are too few to be seen directly.
Clinical diagnosis
Diagnosis of trypanosomiasis can also be based on the signs that are associated with the 
disease. The disadvantage of this method is that these signs are not indicative of 
trypanosomiasis alone. For example, malnutrition and intestinal helminthiasis will 
normally show the same clinical signs as animals suffering from chronic trypanosomiasis.
Table 1.4 The direct and indirect tests used for diagnosing trypanosomiasis. 
(Hopkins, 1995)
Direcl tests Indirect tests
Trypanosomes
not
concentrated
Trypanosomes
concentrated
Detection 
of antigen
Detection of 
anti­
trypanosomal 
antibodies
Detection of 
trypanosomes
Detection of 
chromosomes
1. Wet films of 
blood or lymph.
2. Giemsa 
stained thick 
and thin smears.
3. Tail tip 
capillary wet 
blood smear.
1 .Intact 
capillary (Woo 
technique)
2. Buffy coat 
wet smear.
1. Antigen
trapping
ELISA.
1. Antibody 
trapping 
ELISA.
2. Indirect 
Fluorescent 
Antibody test 
(IFAT).
1. In vivo 
cultivation by 
inoculation of 
the suspect 
blood into rats 
or mice.
1. polymerase 
chain reaction 
(PCR)
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Parasitological methods (Direct tests)
As mentioned above these tests depend on demonstrating the presence of the infecting 
organism. This is done by the examination of a sample of blood or other body fluids or 
tissues.
a. Wet blood film
A drop of fresh peripheral blood obtained from an ear vein or jugular vein is placed on a 
microscope slide and covered with a coverslip. This is examined under the microscope 
using x400 magnification. The trypanosomes are detected by their movement among the 
blood cells.
This method provides a quick and convenient means of detecting the presence of 
trypanosomes.
b. Wet film of lymph or cerebro-spinal fluid (CSF)
In this method lymph juice from a lymph node or CSF is placed on the slide and covered 
with a coverslip and examined as in the wet blood film. The disadvantage of this method 
is that it is difficult to obtain samples from animals, especially cattle. This method is 
useful mainly in the diagnosis of T. brucei gambiense in man.
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c. Thin blood smears
A drop of flesh blood is placed on a slide which is placed horizontally on a table. Using 
another slide (spreader) placed at 45° to the one on the table, the drop of blood is spread 
into a thin layer of blood. This is dried by waving the slide in the air. After drying the 
slide is fixed in methanol and stained with Giemsa stain.
Thin blood films preserve the morphology of the trypanosomes and hence are useful in 
morphological differentiation of species.
d. Thick blood smears
Thick blood smears are prepared by putting 2-3 drops of blood onto a slide and 
spreading it to an area of about 1 cm in diameter with a comer of a slide. To avoid the 
blood smear floating off the slide during staining it is advisable to gently heat the slide 
during drying for about 2-3 hours at 37°C, or leaving the slide at 37°C overnight (Shute 
and Maryon, 1966). After drying, the slide without fixing, is stained in Giemsa stain. 
Lysis of the erythrocytes will occur during staining if the slide is not fixed. This makes it 
possible to examine a much thicker smear.
Thick smears are useful for the detection of scanty trypanosomes.
e. Intact capillary (Concentration, Woo technique)
Blood in a capillary tube is centrifuged in a micro-haematocrit centrifuge for 5 minutes. 
Without breaking the tube it is examined for trypanosomes at the cell/plasma interface 
or white layer (buffy coat) in the intact capillary (Woo and Rogers, 1974).
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f. Buffy coat wet smear (Concentration technique)
After the capillary tube is centrifuged in the micro-haematocrit centrifuge, the tube is 
broken just a millimetre below the cell/plasma interface. A drop of the cell/plasma 
mixture i.e. the buffy coat and a few red blood cells are placed on the slide, covered with 
a coverslip and examined for trypanosomes under the microscope.
The buffy coat technique is capable of detecting trypanosomes at about 100 
trypanosomes per 1 ml of blood (Woo and Rogers, 1974).
g. Rodent inoculation
Blood from a suspected animal is mixed with phosphate buffered saline glucose, pH 8.0 
and inoculated into rodents intraperitoneally. The development of infection in the 
rodents, usually mice, is monitored in blood samples obtained by tail venesection. For T. 
brucei brucei and T. brucei rhodesiense this method is much more sensitive than 
examination of thick and thin films (Baker, Sachs and Laufer, 1967).
The rodent inoculation technique is useful when the parasitemia is scanty. One 
disadvantage of this technique is that some species such as T. vivax are not rodent 
infective.
Sero-immunological techniques (Indirect tests)
These tests identify the product of the trypanosomes or antibody produced by the host as 
a specific response to the presence of the parasite or its by-product.
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a. Indirect Fluorescent Antibody Test (IFAT)
The fixed trypanosome antigen is prepared in suspension in a mixture of 80% cold 
acetone and 0.25% formalin (Katende et al., 1987), and used to coat the 
immunofluorescent slide. Test serum is added to the coated slide. The fixed 
trypanosomes on the slide detect antibodies in the serum samples. The test measures 
directly the interaction between the antigen and antibody. The preparation is examined 
under the UV microscope.
b. Sandwich ELISA technique for antibody and antigen detection
In the antibody detection ELISA, trypanosome antigen is adsorbed onto polystyrene 
microwells that capture the circulating antibodies in test serum samples.
The disadvantage of the antibody technique is that the detected antibodies persist in the 
animal blood for a long time after the trypanosomes have been cleared. Because of this it 
is difficult to differentiate a present infection from a past infection (Luckins et al., 1979)
The technical basis of the antigen detection ELISA is that the monoclonal antibody is 
used to coat micro-plates or polystyrene tubes. Test serum is added to the coated plates. 
The antigen in the serum is captured or trapped by the coated antibody. A second 
antibody, which is enzyme-labelled, is added and the labelled antibody will bind to the 
free combining sites of the captured antigen. A suitable substrate and chromogen are 
added and the colour change is detected visually or by spectrophotometer 
(Trypanosomiasis ELISA kit, Bench Protocol, Version - TRP 1.1, 1994).
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c. Polymerase Chain Reaction technique (PCR)
The technique is used to amplify specific regions of an organism’s DNA to levels where 
the DNA fragment can be identified. The amount of DNA is easily seen after staining 
with DNA-binding reagent when the reaction products are separated by electrophoresis 
in a gel.
The disadvantage of this method is the use of radioactive chemicals (ILRAD reports, 
October 1992).
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Economic Impact of Trypanosomiasis
Cattle are highly valued for the draught power and the manure which they provide in 
rural areas. To a rural farmer they are a sign of wealth and represent investment and 
because of this they are slaughtered only for important occasion such as social 
ceremonies (e.g. initiation ceremonies, traditional weddings). They are also slaughtered 
when farmers want to realise large sums of money from the sale of meat to pay for major 
costs such as school fees. In most rural areas, people depend on small ruminants and 
poultry as a source of protein (Connor, 1989).
Direct losses caused by trypanosomiasis are due to the presence of the disease in the 
livestock population. They include production and reproduction losses resulting from 
mortality, morbidity and infertility and the cost of implementing and running 
trypanosomiasis control operations. The annual costs of the disease, including both 
production losses and control costs, are estimated to be more than US$ 500 million per 
annum (ILRAD, 1993).
Indirect losses are due to the risk of the disease. They include exclusion from tsetse- 
infested areas, reduced livestock production levels due to restricted grazing, and reduced 
crop production due to exclusion or limitation of draught power.
Owing to the impact that trypanosomiasis has on the rural economy there is a need to 
control this disease. However without the implementation of carefully planned rural 
development, there is a real risk that human activities and increased livestock numbers, in 
excess of the land’s carrying capacity, will lead to irreversible degradation of the
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environment. In view of this, tsetse and trypanosomiasis control activities must be done 
in conjunction with land use planning.
Trypanosomiasis control 
Introduction
Methods of controlling trypanosomiasis may be aimed at the insect vectors or at the 
parasites in domestic animals.
Vector control
a. Biological control
Clearing of vegetation and game elimination
Old methods of tsetse control that had been used with varying degree of success include 
modification of the vegetation cover by either selective (partial clearing) or complete 
(total clearing) felling of trees and shrubs. By doing this the tsetse are denied a suitable 
habitat. Another method was the destruction (shooting) of larger wild game on which 
tsetse flies depend for their food. In Rhodesia (now Zimbabwe) this method proved to be 
successful in the 1930s (Mulligan, 1970) as large areas of the country were freed from 
tsetse by shooting large wild animals in the Zambesi basin. One disadvantage of the game 
and vegetation destruction methods is that it provoked strong opposition from 
conservationists.
Sterile insect technique
This is a recent concept in entomology which involves the release of large numbers of 
captive-bred male tsetse, made infertile by exposure to calculated dose of gamma
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radiation, into an indigenous target population. The population into which the sterile 
males are released, must have been reduced by other methods, to levels at which sterile 
males can successfully compete with the wild non-sterile males. Knipling (1963) 
estimated that an initial 3:1 release ratio of sterile to wild males, followed by a gradually 
decreasing release rate could eradicate a low-density population of flies in twelve 
months. The concept behind this method is that all wild females mated by the sterile 
males will fail to breed. The desired minimum mating ratio is 1 male to each of 4 females 
(Dame and Ford, 1968).
Knowledge of seasonal fluctuations in feeding, dispersal, mating behaviour, reproductive 
status, birth and death rates and length of life of the target species is important. This 
helps in evaluating the fluctuations in density and reproductive viability of the target 
population. It also helps in estimating the relative viability of the released sterile males 
(Mulligan, 1970).
b. Chemical control
Methods of applying insecticides fall into two groups: (1) residual treatments applied to 
vegetation, food, traps and pupation sites, and (2) non-residual treatments applied by 
aircraft, chemical smoke generation and ground-based fogging machines.
Residual treatment
This method became available with the introduction of organo-chlorine insecticides. The 
only use for insecticides against tsetse before 1946 was the use of pyre thrum sprays in 
de-flying chambers (Mulligan, 1970). In the 1950s DDT and dieldrin were used in
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ground spraying to reduce tsetse fly populations by spraying tree trunks and low 
branches where tsetse rest during the hottest and brightest hours of the day.
Non-residual treatment
Under this method, ultra-low-volumes of endosulphan, an organo-chloride compound 
with low residual effects are sequentially aerially sprayed on the infested areas using 
fixed-wing aircraft in open country habitat of such species as G. morsitans. In closed 
vegetation, helicopters are favoured for spraying against.riverine species.
The aim of the sequential aerial spraying is to kill all adult flies with the first spray and 
then the new flies emerging from puparia in the four to five subsequent sprays.
The high cost and expertise needed are some of the disadvantages of this method.
Traps and targets
Traps and targets probably provide the best method of vector control for most situations. 
Currently targets are the method of choice for controlling tsetse in most countries.
Traps were first used for controlling tsetse by Harris (1930) in Zululand. Large numbers 
of G. pallidipes were caught using his own designed Harris trap. In 1970s serious 
interest in the use of traps was revived. The introduction of host odours to attract tsetse 
increased the efficiency of traps by up to 30 times. Trapping 4% of the population of 
adult females each day will reduce an isolated tsetse population by 99% in six months. 
Targets are sheets of cloth usually black or blue sometimes with netting attached, which 
are impregnated with insecticides such as deltamethrin. To attract flies they are baited 
with animal odours such as acetone, phenols and octanol. Flies that make contact with 
this cloth or land on it, pick up a lethal dose of insecticide.
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The Regional Tsetse and Trypanosomiasis Control Programme (RTTCP) a regional 
programme covering, Malawi, Mozambique, Zambia and Zimbabwe is trying to use this 
method to control tsetse fly in the common flybelt of these countries. The programme is 
using a density of 4 targets per square kilometre.
Cattle sprayed with insecticides are sometimes used as mobile targets. In 1984 trials 
began in Zimbabwe to test the efficacy of the pyrethroid deltamethrin (“Decatix”, Cooper 
(Zimbabwe) LTD) and since then has been widely used to control tsetse in that country. 
The insecticide is used both as a dipwash or pour-on.
Trypanotolerant Livestock
Trypanotolerant cattle such as the N’dama can be reared in infested areas. This breed can 
tolerate levels of infection with trypanosomiasis that other breeds can not withstand. 
Chemotherapy is used to treat the few cases that occur. However these breeds are 
largely restricted to West Africa.
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Parasite control using drugs
a. History of the trypanocidal drugs 
Potassium antimony tartrate (tartar emetic)
The history of trypanocides date as far back as the early part of this century. The first 
active substances found were dyes and later arsenical and antimonal compounds. 
Plimmer and Thompson (1908) tested potassium antimony tartrate (tartar emetic) in 
laboratory rodents and showed that T. brucei and T. evansi could be eliminated. Bevan 
(1928) and Curson (1928) confirmed the efficacy of the use of the tartar emetic against 
T. congolense and T. vivax infection in cattle.
The use of the tartar emetic continued until the early fifties when it was discontinued 
because of high mortality.
Suramin
Suramin, a synthetic compound was the next to be developed in Germany during the 
1914-18 war, but only became available in 1920. Knowles (1925) experimentally showed 
its efficacy against T. equiperdum infections. He also showed that naturally occurring T. 
evansi infections in camels could be treated with this drug.
Suramin continues to be used to date.
Antimosan
As a result of continued research on potassium antimony tartrate, antimosan, an 
analogous sulfonated pyrocatechol derived from trivalent antimony was developed and
22
Parkin (1931, 1935 b) found it to be effective against T. congolense and T. vivax but less 
effective against T. brucei.
Styrylquinolines
These were demonstrated by Browning et al., (1926) to be active trypanocides against 
organisms of Trypanozoon subgenus. However they did not act rapidly on trypanosomes 
and were systemically toxic. They also produced serious reaction at the site of injection.
Surfeit C
Surfen C, a 4-aminoquinoline derivative was reported by Jensch (1937) to have marked 
activity against T. congolense, but in field trials in Africa it produced unacceptable toxic 
reactions.
Phenanthridines
Phenidium chloride a phenanthridine was reported by Browning et al (1938) to be active 
against the Trypanozoon subgenus. The drawback with this drug was its low solubility 
and narrow therapeutic index.
Dimidium bromide, another phenanthridine, which was readily soluble was shown by 
Carmichael and Bell (1944) to be active against T. congolense in the field. This drug had 
its own disadvantages in that it produced photosensitisation and local reactions (Evans, 
1948). Drug resistance had also become widespread by 1952.
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Quinapyramine
As a result of restructuring the surfen C molecule, a bis-quartemary salt (quinapyramine 
dimethosulfate) was synthesized by Barrett et al (1953) and was demonstrated 
experimentally by Curd and Davey (1949) to be active against trypanosomes pathogenic 
to livestock in Africa. Its efficacy was also demonstrated in the field by Davey (1950). 
However in Equidae this drug caused severe systemic reactions.
A mixture of quinapyramine dimethosulfate (3 parts) and the insoluble quinapyramine 
chloride (4 parts) was introduced as a prophylactic.
Serious drug resistance to quinapyramine soon emerged and it is no longer in use. 
Homidium
Homidium bromide (an aminophenanthridium compound) was developed from dimidium 
bromide and was reported by Warkins and Woolfe (1952) to be effective against T. 
congolense and T. vivax at 1 mg/kg body weight. This drug was less toxic (Ford et al., 
1953 a.b) than dimidium bromide.
As a result of the availability of homidium and quinapyramine dimethosulphate, mass 
treatment of cattle in contact with tsetse was made possible as demonstrated in Northern 
Nigeria where 641,000 cattle were treated in 1957-58 as compared with only 45,000 
treated in 1951-52 (Mulligan, 1970). Resistant strains of T. congolense began to be 
identified and by 1966 Jones-Davies and Folkers reported widespread resistance. Despite 
this problem the drug, generally known as Ethidium®, is still used in many countries.
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Diminazene aceturate
Fussganger (1955) reported trials with a new aromatic diamidine by the name of 
diminazene aceturate (marketed as Berenil®). A dose of 3.5 mg/kg body weight was 
reported to cure T. congolense and T. vivax infection. A much higher dose was required 
to treat T. brucei infections.
It had the added advantages of having a wide therapeutic index and being babesicidal. 
MacLennan (1968) reported that it virtually replaced both quinapyramine and homidium 
in Northern Nigeria.
Pyrithidium bromide
Pyrithidium bromide, synthesised by substituting the pyrimidyl moiety of quinapyramine 
into a phenanthridine resembling phenidium was reported by Watkins and Woolfe 
(1952). This was withdrawn, in 1985 (Connor, 1989), due to the emergence of drug 
resistance.
Isometamidium
The next drug to be marketed was isometamidium. It was synthesised from homidium as 
a compound named metamidium, (Wragg et al.,1958). Metamidium consisted of four 
isomers. The active component that was isolated in pure form (Berg, 1963) from 
metamidium was marketed as Samorin®
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Melarsomine
Melarsomine (Raynaud et al., 1989) is the most recently introduced trypanocide used in 
domestic livestock. This was synthesised by combining melasen oxide with cysteamine in 
1985 by E. Friedheim. It is active against members of the Trypanozoon subgenus 
(Raynaud et al., 1989), particularly T. evansi. It is marketed as Cymelarsen®.
The search for new drugs for controlling animal trypnosomiasis has been limited by the 
high cost of screening, development and production, and the anticipated low levels of 
profit from marketing trypanocides as the disease affects the poorest nations.
b. Classification of drugs
Drugs can be classified according to their chemical structure (Table 1.5.) and properties 
or various aspects of their biological activities (Mulligan, 1970).
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Table 1.5 Characteristics of drugs used for the treatment and prophylaxis of Animal 
Trypanosomiasis. C = curative, P = prophylactic, i.m. = intramuscular, i.v. = intravenous, 
s.c. = subcutaneous, Dose is in milligrams per kilogram of body weight
(Leach and Roberts, 1981)
Drug Type Animal Field use Dose Toxic effects Comments
showing infection
chemical grouping
Homidium bromide C Cattle, T. conglense 1.0 i.m. Local tissue The bromide is
and homidium small T. vivax damage if soluble only in
chloride ruminants, given s .c .; hot water,
(phenanthridine) horses,
pigs
liver damage 
when given at 
high dosage
whereas the 
chloride is 
soluble in cold 
water. Either 
salt can be used 
alternatively 
with
diminazene 
aceturate to 
reduce the 
incidence of 
drug resistance.
Diminazene aceturate C Cattle, T. conglense 3.5 i.m. The drug is
(aromatic diamidine) small
ruminants,
dogs
T. vivax more rapidly 
excreted than 
other
trypanocides 
and is active 
against 
homidium- 
resistant 
infections; it is 
inactive against 
T. simiae
Isometamidium P Cattle T. congolense 0.5-2 Similar to The drug is less
chloride T. vivax i.m. those of toxic than
(phenanthridine- homidium. homidium. It is
aromatic amidine) soluble in cold 
water and is 
heat sensitive. 
Prophylaxis 
lasts 2-4 
months, 
depending on 
the challenge. 
The dose 
should be 
determined by
C Cattle T. congolense 
T. vivax
0.25- 
1.0 i.m.
the intensity of 
challenge. 
Higher doses 
may be given 
for drug 
resistant 
infections.
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c. Mode of drug action
Trypanocides currently used to control tsetse-transmitted trypanosomiasis differ in their 
mode of action.
Diminazene aceturate
Diminazene aceturate is an odourless, yellow powder with a solubility of 1:14 in water 
at 20°C and slightly soluble in alcohol, ether and chloroform. A dose of 3.5 mg/kg body 
weight given intramuscularly will eliminate infections with T. congolense and T.vivax but 
5 mg/kg is required to eliminate T. brucei infections (Fussganger and Bauer, 1960). It is 
also active against Babesia species in cattle, sheep, horses and dogs (Kuttler,1981). 
Diminazene aceturate is a curative drug and after injection is rapidly metabolised and 
excreted through the kidney. This characteristic of quick clearance, reduces the risk of 
resistance developing through prolonged exposure of parasites to sub-lethal levels of the 
drug.
Diminazene aceturate has selective inhibitory action on kinetoplast DNA synthesis 
(Newton and Le Page, 1967, 1968).
Homidium
Homidium bromide and homidium chloride belong to the phenanthridine class and are 
equally active in vivo (Leach and Roberts, 1981). At a dose rate of 1 mg/kg body weight 
given intramuscularly, they are both used as therapeutic agents against T. congolense and 
T. brucei.
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Though eliminated rapidly from the body, its elimination is slower than diminazene and 
because of this, it has some prophylactic activity varying from 2 to 19 weeks against field 
challenge (Leach et al., 1955; Dolan et al., 1990, 1992).
Homidium blocks the synthesis of nucleic acid through intercalation between DNA base 
pairs, inhibition of RNA polymerase and DNA polymerase and incorporation of nucleic 
acid precursors into DNA and RNA (Kinabo, 1993).
Isometamidium
Isometamidium chloride is a phenanthridine-aromatic amidine marketed as both a 
therapeutic and prophylactic agent. The recommended dose range for prophylactic 
purposes is 0.5-1.0 mg/kg body weight. A dose rate of 1.0 mg/kg body weight confers 
prophylaxis to cattle for 2-22 weeks (Kirkby,1964; Pinder and Authie, 1984; Whitelaw et 
al., 1986; Peregrine et al., 1991). Variation in drug susceptibility between different 
trypanosome populations appears to be the major factor determining the duration of 
prophylaxis (Peregrine etal., 1991).
After intramuscular injection a local tissue reaction occurs at the injection site. This 
encapsulates the drug and over a period of weeks the drug leaks into the blood stream to 
provide protection. The mode of action on trypanosomes is similar to the one described 
for homidium i.e. blockage of nucleic acid synthesis.
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d. Drug resistance 
Introduction
The appearance of resistant strains of trypanosomes has been associated with the 
extensive and prolonged usage of the few drugs (diminazene, homidium, isometamidium, 
quinapyramine and suramin) available on the market. Because of this some of the drugs 
such as quinapyramine have been withdrawn (Ndoutamia et al., 1993).
Natural resistance
“Natural resistance of a trypanosome strain or species to a drug is that variation in drug 
sensitivity shown by trypanosomes that is not dependent on previous exposure to the 
drug concerned” (Leach and Roberts, 1981). For example at a recommended dose rate 
homidium is more effective against T. vivax than against T. congolense. In this situation 
T. congolense will show a higher rate of relapse infection than T. vivax (Leach and 
Roberts, 1981).
Development of resistance
Under-dosing is thought to be the main cause of drug resistance in the field. Under­
dosing occurs when the concentration of trypanocides in the animal body is below the 
curative level.
Under-dosing can happen in several ways (Whiteside, 1961):
i) Through incorrect estimation of body weight or incorrect dosage when large numbers 
of animals are involved.
ii) Irregular treatment or termination of treatment while animals are still at risk.
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Cross-resistance
The similarities in chemical structure between drugs account for some of the factors that 
favours development of cross-resistance (Mulligan, 1970). The modification of common 
receptor sites on trypanosomes during development of resistance may be the important 
factor (Mulligan, 1970). The pattern of cross-resistance as analysed by Whiteside, 1961 
is as shown below (Table 1.6).
Table 1.6
Cross-resistance patterns of the drugs used in cattle trypanosomiasis, (after Leach and 
Roberts, 1981)
Response of trypanosomes to:
Trypanosomes 
resistant to
Quinapyramine Homidium Prothidium Metamidium Diminazene
Quinapyramine R ++ + + ++
Homidium + R + + 0
Prothidium + ++ R 0 9
Metamidium + ++ + R 0
Diminazene 0 0 0 0 R
R : direct resistance.
+ : cross-resistance to curative dose 
++ : cross-resistance to higher dose 
0 : no cross-resistance
As a result of cross-resistance analysis, Whiteside (1960a) developed the concept of 
“sanative” pairs of drugs. A “sanative” pair being that pair of curative drugs which do 
not induce resistance to each other when used alternatively. Homidium and diminazene 
and isometamidium and diminazene are examples of two such sanative pairs.
31
Methods used to identify drug resistance
(a) Field data
It is possible to distinguish the incidence of new infections by collecting parasitological 
data once every two weeks from sentinel animals treated with only diminazene aceturate.
(b) Large animals
Large animals can be used to characterise the drug-resistance phenotype of trypanosome 
populations (Gray and Roberts, 1971, Codjia et al., 1993). Field isolates are inoculated 
into large animals (cattle or goats) under laboratory conditions. At the peak of 
parasitaemia the animals are treated with a drug and monitored for relapse infection for 
180 days. The advantage of this is that data generated in this way is directly applicable to 
the field. The disadvantage is the purchase and maintenance of large animals is very 
expensive. It also takes up to six months to have definitive data (Peregrine, 1994). In 
addition large numbers of isolates cannot be screened.
(c) Laboratory animals
Mice and rats are normally used in conventional drug sensitivity tests. Mice are infected 
with approximately 1 x 105 trypanosomes by intraperitoneal inoculation. Drug is 
administered at the first detection of trypanosomes. The mice are then monitored for 60 
to 90 days for relapse.They have the advantage over large animals in that they are not as 
expensive to purchase and maintain. However results obtained from rodent experiments 
may not be highly predictive for cattle (Sones et al, 1988). It also takes about 30-90 days
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to confirm permanent cure (Sones et al, 1988) and not all field isolates grow in 
laboratory rodents (Hawking, 1963).
(d) In Vitro cultivation
The use of in vitro systems (Borowy et al., 1985 ) or the use of both in vitro and in vivo 
as in the drug incubation infectivity test (DIIT) (Kaminsky et al., 1990, 1993) may be 
used for characterising the drug sensitivity of trypanosome populations. However, using 
this test it is not possible to screen large numbers of isolates and prediction of the drug 
sensitivity of the trypanosome population in the host using data obtained in vitro is not 
yet possible (Kaminsky, 1990).
(e) Use of assays to determine the concentration levels o f drug in sera
The use of assays that quantify the concentrations of the drug in the sera in combination 
with a trypanosomiasis diagnostic test can be used as an indirect method for the 
detection of drug resistance (Peregrine, 1994). The assay that will be able to rapidly 
quantify the concentration of the drug in large numbers of samples will be the assay of 
choice.
Drug detection assays
Several assays have been previously described for the detection of trypanocidal drugs 
(Philips et al., 1967; Perschke and Vollner, 1985; Kinabo and Bogan, 1988) but all have 
serious shortcomings.
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(a) The High Performance Liquid Chromatography (HPLC) as described by Perschke 
and Vollner (1985) is used to analyse trypanocide drugs in sera or plasma of treated 
animals. The drugs that can be detected by this method include, homidium bromide, 
homidium chloride, isometamidium chloride, quinapyramine chloride and quinapyramine 
sulphate.
The steps followed in this assay are: separation of plasma from blood cells by 
centrifugation, pre-concentration on small silica gel columns, elution with acidified 
solvent and finally HPLC measurement with UV or fluorescence detection.
A large volume of serum, up to 10 ml is used in the assay. The lower detection limits are 
5 ng/ml serum for homidium, 3 ng/ml serum for quinapyramine and 20 ng/ml for 
isometamidium.
The disadvantage of this method is that it requires large volumes of samples and because 
the assay is based on acidic cleavage of isometamidium to homidium, the test will not 
distinguish between homidium and samorin if homidium is in the sample (Perschke and 
Vollner, 1985).
(b) A radio-immunoassay method for isometamidium (ISSM) measurement was 
described by Kinabo and Bogan (1988). The assay used antibodies raised in sheep 
immunised against the drug cross-linked to human serum albumin. The radiolabelled 
isometamidium (14C-ISMM) was used as a radioligand. Using this test the limit of 
detection of isometamidium in serum without prior extraction was 5.8 pmol/tube.
The limitations of this assay was that it was not very sensitive and it required the use of 
radioactive drug.
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(c) Solid-phase extraction and ion-pair reversed-phase HPLC for analysing 
isometamidium in serum and tissues was also developed by Kinabo and Bogan (1988) 
and involved the hydrolysis of samples enzymatically and cleaning on a solid-phase 
system (C8 Bond Elute column). After this step the drug was chromatographed by an 
ion-pair reversed-phase technique using heptane sulphonate as a paired-ion and 
triethylamine as a counter-ion reagent. Detection was by fluorescence at 593nm. The 
lower limit of detection as demonstrated by Kinabo and Bogan (1988) was 10 ng/ml of 
serum and 500 ng/g of tissue.
(d) An enzyme-linked immunosorbent assay (ELISA) for the detection of isometamidium 
in bovine serum was developed and validated by Eisler et al. (1993). In this assay the 
liquid-phase isometamidium (isometamidium in the sample) competes with solid-phase 
bound isometamidium-protein conjugate for biotinylated sheep anti-isometamidium IgG. 
The specific IgG is detected by streptavidin-peroxidase using tetramethylbenzidine for 
colour development. The more the colour development the less the free isometamidium 
in the serum of the treated cattle. Calibration of the assay is done by four-parameter 
logistic curve-fitting. The same procedure is followed for the homidium ELISA assay.
The lower limit of detection of isometamidium is about 0.1 ng/ml of serum.
The assay is the most precise, sensitive and reproducible technique that can be used for 
the quantification of the drug in bovine sera. The assay may be used in the development 
of rational chemoprophylactic drug regimens and as an indirect method for detecting 
isometamidium resistance in the field (Eisler et al., 1993).
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Trypanocidal delivery systems 
Introduction
Several of the few trypanocides that are currently used to control trypanosomiasis in 
domestic animals, produce local toxicity at injection sites (Peregrine, 1994). Furthermore 
many of these drugs only offer short periods of prophylaxis. In order to prolong the 
prophylactic activity and reduce local toxicity at the injection sites, different formulations 
(carrier or delivery systems) have been produced and evaluated. These include: suramin 
complexes, dextran complexes, liposomal formulations, carrier erythrocytes and 
homidium and isometamidium polymers (Peregrine, 1994).
Suramin complexes (suraminates)
At normal physiological pH, suramin is an anion whereas diminazene, homidium, 
isometamidium and quinapyramine are cations. When either of these cationic drugs is 
mixed with suramin a precipitation (suramin complex) is formed. Williamson 
(Mulligan, 1970) formulated complexes in this way and showed that there was 
considerable reduction in the toxicity of the cationic drug component for rats by a factor 
varying from 3x to 33x. In the first prophylactic trial in cattle Desowitz, (1957) observed 
similar reductions in toxicity. “Depot” formulation at the injection site enhanced 
prophylactic activity in small animals. In cattle homidium-suramin complexes offered the 
longest period of protection. After a single dose of 10 mg/kg of homidium-suramin 
complex, a minimal period of protection of thirteen months was obtained in small 
numbers of experimental cattle (Desowitz, 1957). The use of this complex was not 
recommended as a result of the reaction at the injection site if given by the subcutaneous
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route in cattle (Stephen, 1958). A dose rate of 40 mg/kg body weight of quinapyramine- 
suramin-complex was recommended for T. simiae infection in pigs (Stephen, 1966). 
However there have been no recent reports of the use of suramin-complexes.
Dextran complexes
This delivery system involves complexing trypanocides with dextran sulphate (molecular 
weight 500 000). James (1978) and Aliu and Chineme (1980) complexed isometamidium 
with dextran sulphate and in their studies they found that the toxicity of the drug for 
rodents was greatly reduced. No definitive conclusion can be made about the 
prophylactic activity of the complexes because the activities varied greatly between the 
studies (Peregrine, 1994).
Liposomal formulation
Liposomes are small phospholipid vesicles used as carriers of therapeutic agents 
(McKellar, 1994). In order to reduce local toxicity and prolong the prophylactic effect of 
diminazene, homidium and isometamidium, Ruck and Hopkins (1987) produced multi- 
lameller liposomes into which the drugs were incorporated. They evaluated these 
formulations in cattle in the field and observed a small increase in the prophylactic effect 
of diminazene and homidium. Local toxicity was reduced when the drugs were 
administered in these formulations. Standardisation of these formulations was a problem 
and because of this further evaluation has been retarded (Peregrine, 1994).
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Carrier Erythrocytes
Red blood cells (rbcs) are osmotically active and because of this, pores in their 
membrane can be opened and closed (Deloach and Wagner, 1988). This allows entry and 
entrapment of exogenous molecules into the rbcs. In studies to prolong the prophylactic 
effect of homidium, Deloach (1985) utilised this principle to encapsulate a maximum of 5 
mg of the drug into 1010 rbcs. This means that 20 ml of packed rbcs containing the drug 
would contain sufficient drug for a 100 kg animal (Deloach, 1985). The method seems 
impractical for field use and no experimental trials in ruminants have been reported 
(Peregrine, 1994).
Homidium and isometamidium polymers
De Deken et al. (1989) produced and evaluated the prophylactic effect of a slow release 
cylindrical polymeric device (SRD) in rabbits. The SRD measured 1 cm in length, 1.7 
mm in diameter, weighed 27.1 + 1.3 mg and contained 25 % Ethidium. These cylindrical 
polymeric devices were implanted subcutaneously in the shoulder region. The 11.25 
mg/kg SRD-homidium protected the rabbits against seven challenges with T. congolense 
during a period of more than 300 days while the prophylactic activity of intramuscular 
injection was less than one month. Only very slight or no inflammation occurred at the 
site of the implanted rods.
In a similar experiment, using a different polymer matrix and a lower dosage of 
homidium bromide (1 mg/kg), Geerts et al. (1993) showed that 95% (15 out of 16 
rabbits) remained protected by the SRD until three months post implantation.
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Microscopical examination of the tissue from implantation sites showed very slight tissue 
reaction in most of the rabbits.
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This thesis describes a number of studies to:
1. Evaluate and improve a competitive enzyme immunoassay for the detection of 
isometamidium in bovine serum.
2. The use of an ELISA to measure isometamidium concentrations in the sera of treated 
cattle underfield conditions and as an indirect method for monitoring drug resistance at 
North Nyamphande, Zambia.
3. Evaluate the prophylactic effect of a slow release device containing homidium 
bromide in cattle under field conditions.
4. Influence of the plane of nutrition on the duration of isometamidium prophylaxis in 
sheep.
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Chapter 2
Competitive enzyme immunoassay for the detection of isometamidium 
in Bovine serum; an improved assay using anti-isometamidium 
hyperimmune rabbit serum and isometamidium-horseradish 
peroxidase conjugate produced using a 
n-hydroxysuccinamide-carbodiimide linkage
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INTRODUCTION
Several analytical methods have been developed for measuring concentrations of 
trypanocidal drugs in serum or plasma. These include the spectrophotometric method of 
Philips et al., (1967), high performance liquid chromatography (HPLC) (Persch and 
Vollner, and Kinabo and Bogan, 1988) and radio-immunoassay (Kinabo and Bogan, 
1988). All these methods have their limitations. The spectrophotometric method is not 
sensitive in that it cannot determine isometamidium concentrations lower than 1 |Ug/ml in 
plasma. Perschke and Voller’s (1985) HPLC method is not specific, in that it is an 
indirect method in which isometamidium has to be converted to homidium before 
detection. It also requires a large amount of serum (about 1 ml per sample) on the 
chromatographic column. The limitation of the HPLC method as described by Kinabo 
and Bogan (1988) is that the lower limit of detection of isometamidium is 10 ng/ml in 
serum and about 400 ng/g in wet tissue. The radio-immunoassay (Kinabo and Bogan, 
1988c) is even less sensitive in that the lower limit of detection of isometamidium is 29 
ng/ml of serum.
The competitive enzyme immunoassay (CEIA), developed by Eisler et al., (1993,1996) 
has several advantages over the earlier methods. This ELISA utilised anti-isometamidium 
hyper-immune sheep serum, and an isometamidium-horseradish-peroxidase (HRP) 
conjugate produced using a carbodiimide (CDI) linkage. More recently, attempts have 
been made to adapt the assay for anti-isometamidium hyperimmune rabbit serum and 
isometamidium-HRP produced using n-hydroxysuccinamide (NHS)-CDI linkage. Using 
these reagents a potentially more sensitive assay was obtained, where the amount of
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isometamidium resulting in 50% competition was slightly lower (1.1 ng/ml) than that 
using the earlier reagents (2.2 ng/ml) and cross-reactivity with homidium was reduced 
(M. C. Eisler, personnel communication). The only disadvantage of the ELISA using the 
later reagents was the excessive inter-sample variation observed among the sera from 
untreated animals. This variation was due to the sample 'matrix' i.e. the serum containing 
the analyte. High inter-sample variation due to the matrix effect is a potential problem for 
all such direct non-extraction methodologies, but was particularly pronounced in this 
case. When control sera from cattle which had not been treated with any trypanocidal 
drug were analysed using the competitive ELISA, samples showed very low optical 
densities compared with values obtained using buffer alone, which in effect amounted to 
false positive results for isometamidium.
In this chapter, several experiments were conducted to investigate the cause of the 
variation in the competitive ELISA using anti-isometamidium hyperimmune rabbit serum, 
and isometamidium-n-hydroxysuccinamide-horseradish peroxidase conjugate among 
negative sera collected from untreated animals are described. These included: (a) heating 
the sera to which EDTA (as an anticoagulant) was added for 10 minutes at 100°C; if the 
interfering factor was a protein it could have been denatured by this high temperature,
(b) dialysing the sera before use which would have demonstrated whether the interfering 
factor was one of low molecular weight, (c) using normal rabbit serum as a blocking 
agent in a sample diluent buffer, which might indicate whether the interfering factor 
interacted with the rabbit hyperimmune serum, and (d) use of a sequential saturation 
procedure in which the sera and conjugate were added to the coated microtitre plate at 
different times.
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MATERIALS AND METHODS
Bovine sera
Sera from untreated cattle
Sera were obtained from 20 healthy adult Boran cattle at Kapiti Ranch situated in the 
Athi plains, a tsetse free area of Kenya, and from 20, 1 - 3 month old Boran calves bom 
at Kapiti Ranch and reared at the International Livestock Research Institute (ILRI), 
Kenya. None of these animals had ever received treatment with either isometamidium or 
homidium. Sera were also obtained from 24 Mashona cattle from Makuti on the Zambezi 
escarpment, an area of low tsetse challenge in Zimbabwe (Eisler, et al., 1996). None of 
these cattle were believed to have received treatment with either isometamidium or 
homidium.
Sera from isometamidium-treated cattle
Seven Boran cattle at International Livestock Research Institute (ILRI), Kenya, were 
treated with isometamidium chloride by deep intramuscular injection of a 1 % aqueous 
solution, into the middle third of the neck at a dose rate of 0.5 mg/kg body weight. One 
week later blood samples were collected from a jugular vein and were incubated (without 
anticoagulant) for four hours at 37°C to maximise clotting. They were then incubated at 
4°C overnight and centrifuged at 1500 RPM for 15 minutes, after which sera were 
removed from the clots and aliquoted and stored at - 70°C.
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Rabbit sera
Normal rabbit serum
Normal rabbit serum obtained from rabbits at ILRI, Nairobi small animal unit was kindly 
provided by Mr. Alfred Adema.
Anti-isometamidium hyperimmune rabbit serum
Anti-isometamidium hyperimmune rabbit serum was kindly provided by the Department 
of Veterinary Physiology at the University of Glasgow. The hyperimmune rabbit serum 
had been obtained by immunisation of two rabbits with isometamidium conjugated to 
porcine thyroglobulin using the following procedure. Primary immunisation was by 
subcutaneous injection of isometamidium-thyroglobulin conjugate emulsified in Freund’s 
complete adjuvant (FCA), at two different sites (right side of the neck and right flank). 
Three booster immunisations of isometamidium-thyroglobulin conjugate emulsified in 
incomplete Freund’s adjuvant (FICA) were given 2Vi, 7 and 18 weeks later. Twelve 
days after the final booster, blood was collected for the separation of hyperimmune 
serum, and stored at - 20°C until required for use in the isometamidium ELISA.
Isometamidium conjugated to horseradish peroxidase by an N- 
hydroxysuccinami de-car bod iimide linkage
Isometamidium conjugated to horseradish peroxidase by an N-hydroxysuccinamide- 
carbodiimide linkage was kindly provided by the Department of Veterinary Physiology at 
the University of Glasgow, and had been prepared as follows. A solution of 2 mg N- 
hydroxysuccinamide (Sigma) dissolved in 100 |il 1 mM sodium acetate was added to a 
solution of 10 mg of isometamidium chloride dissolved in 250 |il 1 mM sodium acetate,
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to which 125 |il pyridine (Sigma) was added. The resultant solution was mixed well and 
allowed to stand at room temperature for 2 minutes. A solution of 10 mg l-ethyl-3-(3- 
dimethylaminopropyl) carbodiimide dissolved in 250 |il of 1 mM sodium acetate was 
then added and mixed well.
100 (il aliquots of the reaction mixture prepared above were added at room temperature, 
to a solution of 20 mg horseradish peroxidase in 1 ml of 1 mM sodium acetate solution, 
over a period of 15 minutes with constant mixing. The solution was incubated at 37°C 
for 20 hours, and then dialysed against phosphate-buffered saline (PBS), pH 7.4.
The resulting conjugate was purified further by passing the solution through a Sephadex 
PD-10 column (Pharmacia) and by mixing the coloured portion of the volume for 15 
minutes with 0.5 ml of a 0.25 % (w/v) suspension of activated charcoal (Sigma) in 
distilled water containing 0.025 % (w/v) dextran T70 (Pharmacia, U.K). This was then 
centrifuged at 14,000 rpm, the supernatant removed, mixed with an equal volume of 
glycerol (Sigma) and stored in aliquots at -20 °C.
Trypanocidal drug-spiked bovine serum standards 
Isometamidium standards
A 500 /Ag/ml solution of isometamidium chloride (Samorin®, Rhone-Merieux, France ) 
was prepared by adding sterile distilled water to 50 mg Samorin® powder, to a final 
volume of 100 ml. The solution was mixed well and given time for the powder to 
dissolve completely. This stock solution was then stored in a dark bottle for a maximum 
of three days.
A 1/10 dilution was prepared by adding 1 ml stock solution to 9 ml double distilled 
water. This was further diluted by adding 45 /x1 of the 1/10 diluted solution into 1455 ji\
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normal rabbit serum (NBS) to give a concentration of 1.5 fig)ml Samorin. A 1:3 serial 
dilution was prepared in NBS in tubes labelled 1 to 10 by transferring 500 fil from a 1.5 
/zg/ml Samorin® solution into tube 1, vortex mixing and transferring 500 fil from tube 1 
into tube 2, vortex mixing and repeating the same procedure through to tube 10. The 
pipette tips were changed after every third tube in the serial dilution. The final 
concentrations in ng/ml from tube 1 to 10 were:
500, 166.7, 55.55, 18.51, 6.17, 2.05,0.686,0.229,0.076,0.025
Homidium standards
Homidium-spiked bovine serum standards were prepared in a similar manner using 
homidium bromide (Ethidium®, Laprovet, France), except that a 1/20 rather than a 1/10 
dilution was prepared from the stock solution, so that the resulting standards contained 
only half the drug concentrations present in the corresponding isometamidium standards.
Microplate coating and storage
96-well microplates (Immulon 4, Dynex Technologies, U.K) were coated with rabbit 
anti-isometamidium hyperimmune serum at a dilution of 1/10,000 in carbonate- 
bicarbonate coating buffer (0.1M, pH 9.2), by dispensing 100 fil per well. After 
dispensing, the plates were covered with adhesive plastic plate sealers (Dynex 
Technologies) and incubated overnight at 4°C. The following day the plates were 
removed from the fridge and stored with the well contents in situ at - 20°C for up to two 
months.
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Competitive Enzyme Immunoassay: Equilibrium Method
The assay was conducted as described by Eisler et al., (1996), but using anti- 
isometamidium hyperimmune rabbit serum in place of hyperimmune sheep serum, and 
isometamidium-NHS-CDI-HRP, in place of isometamidium-CDI-HRP. Briefly, test sera 
and standards were prediluted 1/10 in PBS (Appendices 1 and 2) containing 0.05% 
Tween 20 (Sigma) to which isometamidium conjugate had been added. The samples 
were diluted in 8 x 12 racks of polypropylene tubes (Biostat Diagnotics, UK) arranged in 
positions corresponding to the final plate layout. Coated microtitre plates were allowed 
to thaw and equilibrate to room temperature before washing five times in a 1/5 dilution 
of PBS (Appendix 3) in distilled water containing 0.05% Tween 20, and blotted dry. 
Pre-diluted standards and samples were vortex-mixed in the polypropylene tubes (PPN) 
and the contents transferred to duplicate wells of the microtitre plates (100 pi per well) 
using a multichannel pipette. The plates were covered with plate sealers and the well 
contents mixed for 10 minutes at room temperature using a shaker-incubator. The plates 
were then incubated overnight at 4°C.
The following day after equilibrating to room temperature, the plates were washed five 
times with washing buffer as described above, and blotted dry. The colour reaction was 
developed by adding 100 pi per well of a solution prepared by mixing equal volumes of 
the two components of a commercially available sodium perborate / 3,3',5,5' 
tetramethylbenzidine substrate-chromogen system (Vetoquinol, UK), pre-warmed to 37 
°C prior to adding to the plate. The plate was then incubated at 37°C in the shaker 
incubator for 10 minutes after which the reaction was stopped by adding 100 pi per well 
of 1 M phosphoric acid. The optical densities (OD) were read using the Multichannel 
spectrophotometer (Titertek® Multiskan PLUS Mk II) at a wavelength of 450 nm.
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Heat treatment of sera with EDTA
250 pi volumes of 0.1 molar EDTA were added to equal volumes of sera in micro­
centrifuge tubes (Eppendorf), and vortex mixed thoroughly. After closing and piercing 
the flip caps using a needle, the microcentrifuge tubes were heated at 100°C for 10 
minutes using a boiling water bath. After heating, the tubes were centrifuged for 10 
minutes at 16,000 rpm.
Since this heat treatment involved a 1/2 dilution of the sera, it was necessary to modify 
the competitive ELISA (equilibrium method) to allow for this dilution. For this reason, 
instead of preparing 1/10 pre-dilutions in isometamidium-HRP conjugate in 
polypropylene tubes, 50 pi volumes of the heat-treated sera were added directly to 50 pi 
volumes of isometamidium-HRP conjugate in duplicate wells of a washed, coated 
microtitre plate. The conjugate was diluted appropriately such that the final dilution of 
this conjugate in the wells would remain the same as that in the standard procedure. The 
final dilution of serum using this modified procedure was 1/4, rather than the 1/10 
dilution obtained using the standard procedure. After overnight incubation, the colour 
reaction was developed in the normal way.
Dialysis of bovine serum
A suitable length of dialysis tubing (cylindrical volume 0.03 ml/mm, MW cut-off 8000) 
was boiled for 5 minutes in 0.1 M sodium EDTA. Sera were placed in segments of the 
dialysis tubing (one sample per segment), the ends of which were closed by knotting and 
then submerged in a 1 L of PBS diluted 1/10 in distilled water at 4°C with constant 
stirring. The PBS solution was changed after 2 and 4 hours, and thereafter the dialysis
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was allowed to proceed overnight. The following morning the dialysed sera were 
removed from the tubing and tested using the standard competitive ELISA (equilibrium 
method).
Use of normal rabbit serum as a blocking agent for the competitive ELISA 
(Equilibrium Method)
1% normal rabbit serum was prepared by adding 200 |il of normal rabbit serum to 19.8 
ml of PBST and vortex mixing. This preparation was used for the dilution of 
isometamidium-HRP conjugate, and hence subsequently for the pre-dilution of samples 
and standards before addition to the wells of microtitre plates in the competitive 
(equilibrium method).
Competitive Enzyme Immunoassay: Sequential Saturation Method
The sequential saturation (SS) method of competitive enzyme immunoassay was 
conducted in a manner generally similar to the equilibrium method, but with the 
following important differences. Standards and samples were diluted 1/10 in PBST (to 
which isometamidium-NHS-CDI-HRP conjugate had not been added), and incubated 
(100 fil per well) overnight at 4°C in microtitre plates which had been previously coated 
and washed five times as described above. The following day, the microtitre plates were 
washed five times as described above, and 100 |il of a 1/256,000 dilution of 
isometamidium-NHS-CDI-HRP in PBST (pre-warmed to 37°C) was added to every 
well. The microtitre plates were then incubated with constant shaking at 37°C for 15 
minutes, and after a further five washes as described above, the colour reaction was 
developed using the substrate chromogen system as described for the equilibrium 
method.
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Titration of anti-isometamidium hyperimmune rabbit serum and isometamidium
NHS-CDIHRP conjugate
Checkerboard titration was used to determine the optimal dilutions for the anti- 
isometamidium hyperimmune rabbit serum and the isometamidium NHS-CDI-HRP 
conjugate. Four different hyperimmune serum dilutions were compared, and four 
different conjugate dilutions were compared, giving a total of 16 combinations of 
dilutions of these two reagents. On a single 96 well microtitre plate there were therefore 
6 wells for each combination, where 3 tested negative sera and three, serum containing 
1.0 ng/ml isometamidium. The plate layout used is shown in Table 2.1. The optimal 
combination of hyperimmune serum dilution and different conjugate dilution was 
considered to be that resulting in a mean OD for negative serum between 0.6 and 1.2, 
and the highest level of competition due to the isometamidium-spiked serum. The level 
of competition as a percentage was calculated for each combination of hyperimmune 
serum dilution and conjugate dilution as follows:
Competition % = 1 - mean OD for serum containing 1.0 ng/ml isometamidium x 100%
mean OD for negative serum
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Table 2.1 Checkerboard titration for anti-isometamidium hyperimmune rabbit serum and
the isometamidium NHS-CDI-HRP conjugate.
conjugate 
dilution: 
1/64000
1/128000
1/256000
1/512000
Cross-reactivity of homidium in the competitive ELISA
To investigate the cross-reactivity of homidium in the competitive ELISA, results 
obtained using normal bovine serum spiked with homidium were compared with those 
obtained using isometamidium standards. The microtitre plate layouts used are shown
Dilution of anti-isometamidium hyperimmune rabbit serum:
1/2000 1/4000 1/8000 1/16000
1 2 3 4 5 6 7 8 9 10 11 12
A —
B + + + + + + + + + + + +
C —
D + + + + + + + + + + + +
E - —
F + + + + + + + + + + + +
G —
H + + + + + + + + + + + +
-  = Normal bovine serum (no drug)
+ = Normal bovine serum containing 1 ng/ml of isometamidium
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below in Table 2.2. Cross-reactivity was assessed by fitting sigmoidal curves and also by 
comparing the concentration of each drug that resulted in 50 % inhibition of the optical 
density.
Table 2.2 Layout of ELISA plate. X = Normal Bovine Serum, Std = Standard
1 2 3 4 5 6 7 8 9 10 11 12
A X X Std Std Std Std Std Std Std Std Std std
10 9 8 7 6 5 4 3 2 1
B 44 44 44 44 44 44
C 44 44 44 44 44
D 44 44 44
E 44 44 44 44 44
F 44 44 44
G 44 44 44 44
H 44 44 44 44 44 44 44 44
Isometamidium standards were added to Rows A, B, E and F. B was a duplicate of A 
and F was a duplicate of E. Homidium standards were added to Rows C, D (duplicate of 
C ) , G and H (duplicate of G).
Isometamidium conjugate at a dilution of 1 : 128,000 was added to Rows A, B, C and D. 
Homidium conjugate at a dilution of 1 : 40, 000 was added to Row E, F, G and H.
Data Analysis
Absorbances were read using a mutichannel spectrophotometer connected to a personal 
computer. The program Eiaquik® (M. C. Eisler, 1995), was used for the following 
analyses. The means and coefficients of variation (CV) of the absorbances of duplicate
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wells were calculated, and if the CV of any duplicate sample results was more than 12%, 
the result was rejected and the sample re-tested. The concentrations of unknown 
samples were calculated from their absorbances, using four-parameter logistic curves 
fitted to the absorbences of calibration standards. Response-error relationships (Rodbard, 
D., 1981) and precision profiles (Ekins, 1983) were also calculated, and finally results 
were appended to ASCII database files for subsequent analysis, using appropriate 
statistical software.
Inter-sample variation in the competitive ELISA
Inter-sample variance at zero dose was determined in the competitive ELISA by testing 
sera from 24 cattle in Zimbabwe which had not been treated with the drug. Each serum 
sample was tested in duplicate, twice on each of two plates. For each of the two plates, 
two pre-dilutions were prepared for every sample, and each of the two pre-dilutions was 
tested in two duplicate wells.
Experimental approach
Initially, normal (untreated) bovine sera were tested using the competitive ELISA 
(equilibrium method). The same or similar sera were then re-tested in the same assay
a) following dialysis of the serum,
b) following heat treatment with 0.1 M EDTA, and
c) using normal rabbit serum as a blocking agent.
Finally, the same or similar sera were tested using the competitive ELISA (sequential 
saturation method).
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RESULTS
Inter-sample variation using the equilibrium ELISA method:
When sera from untreated Kapiti cattle were tested using the equilibrium ELISA method 
great variation in the optical densities (ODs) was observed. The ODs ranged from 0.208 
to 3.332 and falsely indicated the presence of isometamidium. Below are some of the 
untreated samples that were tested (Table. 2.3 and 2.4). See appendices 4 and 5.
Table 2.3 Observation of variation in the optical densities and false positives 
(isometamidium concentration) of sera from Kapiti cattle.
Animal
number
Optical
density
(nm)
B/Bo
(%)
Drug
cone
(ng/ml)
Animal
number
Optical
density
(nm)
B/Bo
(%)
Drug
cone
(ng/ml)
1441 3.332 214.5 0.000 613 0.602 38.6 2.119
1012 3.115 200.5 0.000 1320 0.592 38.0 2.179
2890 2.318 149.1 0.000 21 0.242 15.4 7.522
721 1.136 73 0.447 607 0.449 28.8 3.330
419 1.132 72.8 0.482 852 0.424 27.1 3.626
163 1.095 70.4 0.544 1126 0.413 26.4 3.756
553 0.998 64.1 0.728 1148 0.368 23.6 4.393
1484 0.995 63.9 0.734 574 0.357 22.8 4.584
874 0.627 40.2 1.978 1344 0.241 15.3 7.560
824 0.623 40.0 1.999 217 0.208 13.2 9.006
nm = wavelength at 450 nm
B = Mean absorbances of the sample
B0 = Mean absorbance at zero dose
B/Bo (%) = Mean absorbances of the sample x 100 
Mean absorbance at zero dose
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Table 2.4 Observation of variation in the optical densities and false positives 
(isometamidium concentration) of sera from ILRI calves.
Animal
number
Optical
density
(nm)
B/Bo
(%)
Drug
cone
(ng/ml)
Animal
number
Optical
density
(nm)
B/Bo
(%)
Drug
cone
(ng/ml)
163 0.975 86.3 0.351 162 1.112 98.4 0.044
153 1.040 92.1 0.200 174 1.161 102.7 0.000
182 1.062 94.1 0.149 177 1.128 99.8 0.007
180 0.846 74.9 0.693 186 1.172 103.8 0.000
179 1.252 110.8 0.000 147 1.102 97.6 0.064
178 0.834 73.9 0.728 269 1.043 92.4 0.192
187 0.984 87.5 0.328 146 1.220 107.9 0.000
295 0.988 87.5 0.317 160 0.894 79.2 0.556
175 0.867 76.8 0.633 164 0.651 57.7 1.423
166 1.233 109.0 0.000 181 1.196 105.8 0.000
nm = wavelength at 450 nm
B = Mean absorbances of the sample
B0 = Mean absorbance at zero dose
B/Bo (%) = Mean absorbances of the sample x 100 
Mean absorbance at zero dose
56
Effect of Dialysis on the equilibrium ELISA:
The result of the four samples dialysed showed that dialysis had no effect on the ODs of 
the samples. There was no significance difference in the ODs of dialysed samples and the 
non-dialysed samples (Table 2.5).
Table 2.5 Optical densities of samples before and after dialysis.
Animal number Optical densities (nm) 
before dialysis
Optical density (nm) 
after dialysis
160 0.470 0.488
164 0.170 0.307
178 0.212 0.260
179 0.826 0.979
nm = wavelength at 450 nm
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Effect of heat treatment with EDTA on the equilibrium ELISA:
When samples were heated with EDTA there was an increase in the optical densities of 
the heated samples. However the optical densities were still low (Table 2.6).
Table 2.6 Optical densities of samples before and after heat treatment.
Animal
number
Optical densities before heat 
treatment
Optical densities after 
heat treatment
164 0.060 0.516
164 0.069 0.495
164 0.075 0.502
164 0.079 0.476
High pool 0.192 0.466
High pool 0.213 0.456
High pool 0.248 0.429
High pool 0.227 0.424
High pool was pooled sera from the animals that were showing high ODs.
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Effect of using 1 % normal rabbit serum as a blocking agent:
The three samples to which 1% normal rabbit serum was added showed no significant 
difference in their optical densities before and after adding the blocking agent (Table. 
2.7).
Table 2.7 Optical densities of serum samples before and after adding 1% normal rabbit 
serum as a blocking agent.
Animal number + 1% normal rabbit serum - 1% normal rabbit serum
High pool 0.423 0.423
164 0.109 0.122
1012 0.753 1.683
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Checkerboard titrations for isometamidium conjugate and anti-isometamidium 
hyperimmune rabbit serum:
The best results were obtained at optimal dilution of 1/8,000 for the anti-isometamidium 
hyperimmune rabbit serum and 1/256,000 for the conjugate. At these dilutions the 
competition level was 37.8% and the B0 value was 0.747 (Table 2.8 ).
Table 2.8 Checkerboard titration results for sequential saturation ELISA.
Anti-isometamidium hyperimmune rabbit serum
1/2,000 1/4,000 1/8,000 1/16,000
Conjugate
dilution
Bo Comp
(%)
Bo Comp
(%)
Bo Comp
(%)
Bo Comp
(%)
1/64,000 1.973 27.7 1.960 30.8 1.746 31.9 0.577 31.0
1/128,000 1.458 32.5 1.409 31.7 1.210 33.4 0.391 28.0
1/256,000 0.899 35.0 0.867 36.8 0.747 37.8 0.275 39.1
1/512,000 0.478 40.1 0.484 41.4 0.415 44.8 0.144 37.9
Comp = competition
B0 = Mean absorbance at zero dose
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Intersample variation (mean response variances) of sera from untreated cattle:
When sera from untreated cattle were tested using the sequential saturation ELISA the 
variation that was observed among the untreated sera using equilibrium ELISA was no 
longer detected. The Percentage Coefficient of Variation (% CV) was 5.8 % (Table 2.9a 
and 2.9b)
Table 2.9a. Optical densities (OD) at 450 nm of 24 individual sera from untreated 
Zimbabwe Mashona cattle.
Animal
number
Optical
density
(nm)
B/Bo
(%)
Animal
number
Optical
density
(nm)
B/Bo
(%)
H 196 0.890 75 P 306 1.215 101.2
P 324 1.070 90.2 P 239 1.203 101.3
P 274 1.068 91.2 BC 1.237 103.4
T 523 1.142 95 P 317 1.205 103.9
T 391 1.082 95.1 P 221 1.300 104.5
P 225 1.145 95.8 P 236 1.298 105.1
P 336 1.170 97.4 P 243 1.283 105.8
P 272 1.220 98.2 J 437 1.288 106.6
P 242 1.212 98.8 194 1.292 106.7
T 478 1.146 99.1 P 228 1.311 107.5
P 238 1.203 99.9 P 229 1.315 108.0
J 156 1.219 101.1 P 235 1.308 109.1
nm = wave length at 450 nm
B = Mean absorbances of the sample
B0= Mean absorbance at zero dose
B/Bo (%) = Mean absorbances of the sample x 100 
Mean absorbance at zero dose
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Table 2.9b Coefficient of Variation (CV) of untreated sera
Total
Samples
Mean Variance SD CV
24 1.20005 0.00491 0.07007 5.8%
SD = Standard deviation
Calculations:
CV = _SD_ x 100%
Mean
SD = I y.fx21 - (Xx)2/Nv N - l
Variance = y /x2) - (Tx)2/N = SD2
N - 1
N = Sample size 
X = Individual observations
Calibration curves
The isometamidium sigmoidal curves fitted well to the four parameter logistic mode. The 
adjusted r2 was > 0.98. Figure 2.1a shows a typical curve obtained using the sequential 
saturation ELISA. The four parameters are shown in Table 2.10a.
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Table 2.10a Isometamidium assay parameters
Parameter Value
A (B0 - background) 1.421
B 0.991
C 0.805
D (background) 0.069
Bo 1.490
10% B0(ng/ml) 11.5
50% Bc(ng/ml) 0.976
90% B0 (ng/ml) 0.054
When the isometamidium sequential saturation assay was adapted for homidium, the 
curves fitted well to the four parameter logistic model (Table 2.10b and Figure 2.1b). 
The adjusted r2 was > 98.
Table 2.10b Homidium assay parameters
Parameter Value
A (B0 - background) 0.444
B 2.148
C 1.701
D (background) 0.165
Bo 0.610
10% Bo (ng/ml) 3.000
50% Bo (ng/ml) 0.638
90% Bo (ng/ml) 0.176
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Figure 
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Drug concentration of treated cattle
The isometamidium levels in the 7 treated Boran cattle were determined by the sequential 
saturation ELISA. The results are shown in Table 2.11. The other serum samples tested 
were from cattle in the field trials conducted in Zambia (see Chapters 3 and 4)
Table 2.11 Isometamidium concentration of treated cattle
Animal no B/B0 % drug concentration 
(ng/ml)
BN 202 17.9 7.75
BN 204 17.6 7.95
BN 205 23.7 4.99
BN 206 19.7 6.66
BN 211 18.9 7.17
BN 219 17.8 7.79
BN 220 27.0 4.00
Cross-reactivity studies of isometamidium with homidium
When homidium spiked sera (standards) were added to a washed plate coated with anti- 
isometamidium hyperimmune rabbit serum and either isometamidium or homidium 
conjugate added, no sigmoidal curves were formed. This showed that no homidium were 
detected by the anti-isometamidium hyperimmune rabbit serum.
When isometamidium spiked sera (standards) were added to a washed plate coated with 
anti-homidium hyperimmune sheep serum and either isometamidium or homidium 
conjugate added, sigmoidal curves were formed. This showed that anti-homidium 
hyperimmune sheep serum was detecting isometamidium. Serum sample that was spiked 
with isometamidium concentration at 0.025 ng/ml reduced the B/Bo to 60%.
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2.4 DISCUSSION
The competitive enzyme immunoassay (sequential saturation method) has proved to be a 
good assay for determining the drug concentrations level in the sera of cattle treated 
under field conditions. The fact that competitive enzyme immunoassay (sequential 
saturation method) can detect concentrations as low as about 0.2 ng/ml of serum 
indicates that the assay is very sensitive. Eisler et al. (1996) found the lower limit of 
detection of about 0.5 ng/ml of sera when they used competitive enzyme immunoasssay 
(equilibrium method). Isometamidium is normally found in low concentrations in plasma 
of treated animals (Kinabo and Bogan, 1988) and because of this very sensitive assays 
are required if low levels of drug in the animals that have been previously treated, are to 
be detected.
The main advantage of the competitive enzyme immunoassay (sequential saturation 
method) over the competitive enzyme immunoasssay (equilibrium method) is that the 
inter-sample variation was not observed when sera from non-treated animals were 
analysed. For the untreated sera the mean response variance for the sequential saturation 
ELISA was less than 6 % while for the equilibrium ELISA it was ~ 10 % (Eisler et al., 
1996). The variation was due to the analyte in the serum. In many assays for drugs, 
hormones, toxins and other similar small molecules, the analyte is extracted from the 
matrix prior to measurement. In the assays being described here, there is no extraction 
step, and the analyte is qualified directly in the matrix. These assays are direct, non 
extraction assays. One way to reduce inter-sample variance (matrix effect) would be to 
employ an extraction step. Such a step would increase the complexity of the procedure, 
amount of equipment required and the cost. Hence the direct non-extraction approach is 
preferable in African laboratories.
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When the equilibrium ELISA was used sera from some of the untreated animals showed 
very low optical densities (ODs) suggesting that they had some levels of drug. This 
suggests there were some factors or molecules in the sera that were interfering with the 
binding of the conjugate or denaturing it. This is likely to be the case because when sera 
and conjugate were pre-diluted in different microtubes and added on to the plate at 
different times, the effect was eliminated. The effect could not be eliminated by either 
dialysing or heating the sera. Blocking agents such as 1 % Normal Rabbit Serum also 
failed to solve the problem.
The main difference between the sequential saturation ELISA and equilibrium ELISA is 
that with the sequential saturation ELISA pre-diluted sera and conjugate are added on to 
the microtiter plate at different times. In brief the stages are: (a) dilution and incubation 
of sera overnight at 4°C. (b) dilution and addition of conjugate and incubation at 37°C 
for 15 minutes, (c) colour development with TMB for 10 minutes. In the equilibrium 
ELISA the sera and conjugate are diluted in the same micronic tube and added onto the 
microtiter plate at the same time.
After the isometamidium competitive ELISA was successfully modified to a sequential 
saturation ELISA, the method was later used for measuring homidium levels in the sera 
of field treated cattle (Chapter Four). The coating of the plate with anti-homidium hyper­
immune sheep serum was done at an optimal dilution of 1/8,000. The conjugate dilution 
was at 1/40,000 in PBST.
The use of the sequential saturation ELISA to determine the concentration of the drug 
levels in the sera that were collected from cattle treated under field conditions (Chapter 
Three and Four) in Africa has proved that the assay is field applicable. A method like this
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is ideal for its intended purpose because trypanosomiasis is a rural problem. Most 
laboratories in rural areas are not well equipped and simple assay like the drug ELISA 
assay is the best.
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Chapter 3
Field studies using ELISA to measure isometamidium concentrations in 
the sera of treated cattle and use the assay as an indirect method for 
monitoring drug resistance at North Nyamphande, Zambia.
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In tr o d u c tio n
In the absence of an effective vaccine, control of tsetse-transmitted trypanosomiasis in 
domestic cattle depends on chemotherapy, control of the tsetse fly vector (Glossina 
species) and the use of trypanotolerant animals. The commonly used drugs in cattle are 
diminazene aceturate, homidium bromide and chloride, and isometamidium chloride 
(Peregrine, 1994). These drugs have been extensively used for over 30 years and drug- 
resistant trypanosomes have appeared in many parts of Africa (Dolan et al., 1990; 
Chitambo et al., 1992; Joshua et al., 1993). Since it is unlikely that new trypanocides will 
be introduced onto the market in the near future, the efficacy of the drug in current use 
must be maintained.
In order to achieve this, control of trypanosomiasis by chemotherapy will have to be 
done on the basis of knowledge of the drug-susceptibility phenotypes of trypanosome 
populations. Various methods have been used to characterise the drug-resistance 
phenotypes of trypanosomes e.g. using laboratory rodents, ruminants, in vitro cultivation 
of trypanosomes in the presence of the drug and statistical analysis of field data 
(Peregrine, 1994). None of these methods is free of constraints; large animals are 
expensive to purchase and maintain, some of the trypanosomes (e.g. Trypanosoma 
vivax) are not rodent infective, and very few laboratories in Africa have the facilities 
necessary to screen large numbers of trypanosome isolates using in vitro cultivation.
In order to overcome the problems associated with these methods, Eisler et al. (1993, 
1996) developed enzyme-linked immunosorbent assays (ELISA's) that are capable of 
determining concentrations of isometamidium in serum samples. Using these assays, 
large numbers of samples can be analysed within a short time. In combination with a
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trypanosomiasis diagnostic test, the assay can be used as an indirect method for 
determining drug resistance; where cattle become infected with trypanosomes despite 
demonstrable circulating levels of the drug that would normally be considered protective, 
the infecting parasites are drug-resistant.
Eisler et al., (1994) used a competitive enzyme-linked immunosorbent assay to determine 
isometamidium concentrations in Boran cattle. In their experiment they concluded that 
trypanosomes persisting at serum isometamidium concentrations greater than 0.75 ng/ml 
were moderately resistant and those persisting at concentration greater than 6 ng/ml 
markedly resistant. In a subsequent paper (Eisler et al., 1996) they concluded that 
trypanosomes persisting in cattle with serum isometamidium concentration of 2.0 ng/ml 
may be considered moderately drug-resistant and at concentrations between 0.4 and 2.0 
ng/ml a low level of drug-resistance.
The objectives of the present study were to determine whether isometamidium 
concentrations may be monitored effectively in individual village cattle under a 
chemoprophylactic regimen and to determine whether isometamidium concentrations 
measured in individual cattle undergoing breakthrough infections, could be used as 
evidence for the presence of drug resistant trypanosomes.
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MATERIALS AND METHODS
Drugs
Isometamidium (Samorin®, Rhone-Merieux, France) was purchased locally in Zambia. 
The drug was prepared by dissolving the required quantity in sterile distilled water, just 
before use. To make up a 2% solution 1 gram of Samorin powder was dissolved in 50 ml 
of sterile water. At least 20 minutes was allowed for the drug to completely dissolve 
before injecting intramuscularly into the gluteal muscles of cattle using a 16 s.w.g. 
needle. Where the total volume of the solution was more than 15 ml per animal, it was 
divided into two equal volumes and injected into two sites.
Monitoring of trypanosome infections and packed cell volume (PCV)
Blood samples were collected from the peripheral ear vein, punctured by a sterile lancet, 
into heparinized capillary tubes. The tubes were centrifuged for 5 minutes in a 
microhaematocrit centrifuge (Hawksley) and the PCV were read using a PCV reader 
(Hawksley). After reading the PCV, buffy coat wet smears were prepared by cutting the 
capillary tubes a few mm below the buffy coat and examined under the microscope using 
the dark ground buffy coat technique (Murray et al., 1977). Thick and thin blood smears 
were also prepared at the crushpen using blood from the ear vein, dried away from direct 
sunlight and stored in a slide box for future fixing and staining with Giemsa. Only the 
thin smears were fixed prior to staining. Thick smears were used for screening 
trypanosomes while thin smears were used for species identification.
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Study site
The trial was carried out at North Nyamphande Settlement Scheme village in Petauke 
district, Eastern Province, Zambia. The settlement scheme lies about 10 km north of 
Petauke, in a tsetse infested area in which many trypanosomiasis cases have been 
reported (Petauke District Laboratory Reports, 1994 and 1995. Unpublished). Samorin® 
and Berenil® have been extensively used in this area for more than ten years. The drugs 
are sold to farmers by employees of the Department of Veterinary and Tsetse Control 
Services, attached to the Belgian Government Assistance of Veterinary Services to 
Zambia (ASVEZA) Project. In this area Samorin® is given to the cattle at three month 
intervals for prophylaxis of trypanosomiasis.
Animals
Seventy Angoni (Sanga) traditional village cattle over six months old were randomly 
selected from a large number of cattle presented by the farmers for the trial. No 
nutritional supplements were given to these cattle. They were exposed to natural tsetse 
challenge and grazed communally on free range.
Body weight determination
A weighband (Dalton, UK) was used to estimate the weight of the animals when 
administering trypanocides.
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Isometamidium treatment
Two weeks following the diminazene block treatment all the 35 cattle in Group 1 were 
treated with a 2% solution of isometamidium chloride injected in the gluteal muscles at a 
dose rate of 1 mg/kg body weight..
Serum sampling
Blood samples were collected from the jugular vein into plain vacutainer tubes (Becton 
Dickinson and Co. USA). The tubes were allowed to clot at ambient temperature before 
transferring them to a fridge at 4°C in the field laboratory. The following day the tubes 
were centrifuged and sera separated from the clot into cryogenic vials (Alpha Labs, 
U.K.). Separated sera were then stored in vials at - 20°C until required for ELISA.
Serum drug concentrations
The Sequential Saturation ELISA described in Chapter Two was used to determine the 
isometamidium levels in the sera of the cattle in the experiment. Sera for preparing 
quality controls (QC) were collected from 7 Boran steers at ILRI. These steers were 
treated with 0.5 mg/kg isometamidium by intramuscular injection. One week after 
treatment whole blood from individual animals was collected and separated using 
standard procedures. Drug concentrations in sera from individual animals and in a pool 
prepared from the individual sera, were determined by ELISA. The mean drug 
concentration for individual sera and the pool was 6.2 ng/ml. Two dilutions of the pool 
were prepared in normal bovine serum (NBS) for use as quality controls (QCs). QC 
(1/5) was prepared by adding 0.8 ml of QC serum to 3.2 ml of NBS. QC (1/2) was 
prepared by adding 2.0 ml of of QC to 2.0 ml of NBS. A third quality control was NBS.
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Evidence for the presence of drug resistant trypanosomes
After determining the levels of isometamidium in the sera of the individual animals, the 
parasitological results were compared with the drug concentrations at each sampling. 
Breakthrough trypanosome infections in individual animals having serum drug 
concentrations above 0.6 ng/ml were judged to be resistant to isometamidium.
Calculation of infection rates
On every occasion of sampling, the infection rate was calculated as the number of 
infected cattle, divided by the number of susceptible cattle. To allow for the period of 
prophylaxis attributable to diminazene (Wellde et al., 1983), and the pre-patent period of 
infection no cattle treated with diminazene within three weeks of sampling were included 
in the number of susceptible cattle.
Experimental design
Two weeks before the trial, cattle were eartagged, screened for trypanosome infections 
and randomly allocated into two groups each of 35 animals. All the cattle were given a 
diminazene block treatment at a dose rate of 7.0 mg/kg body weight to clear them of any 
trypanosome infections before the commencement of the trial. At the beginning of the 
experiment (day zero) all 35 cattle in Group 1 were treated with isometamidium chloride 
at a dose rate of 1 mg/kg body weight. No parasitological monitoring and serum 
collection was done on the day of isometamidium treatment.
Group 2, consisting of 31 animals, was used as control group and received no 
prophylactic treatment with isometamidium.
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Parasitological monitoring was conducted every fortnight following the day of 
prophylactic isometamidium treatment. Serum samples were collected on every occasion 
parasitological monitoring was conducted from cattle in Group 1 and every four weeks 
from cattle in the control group. Individual cattle in Group 1 and Group 2 which 
subsequently developed trypanosome infections received diminazene treatment at a dose 
rate of 7 mg/kg body weight.
RESULTS
Before commencement of the experiment ( -14 days) the infection rate was 37.14 % in 
Group 1 and 19.35 % in Group 2. During the 12 week period of the trial there were 10 
breakthrough infections in Group 1 after treatment with isometamidium at 1 mg/kg body 
weight (Table 3.1 ). In the control group there were 19 infections during the same 
period (Table 3.1).
In Group 1 (n = 30) the first infection was detected in the eighth week after this group of 
cattle were treated with isometamidium (infection rate 3.33 %). Four more infections 
were detected in the 10th week (infection rate 12.12 %) and in the twelfth week 5 more 
infections were revealed (infection rate 18.52 %). In the control group (n = 27) two 
infections (infection rate 7.41 %) were detected at the first sampling (week 4). In the 4th 
week the infection rate was 21.41 % and in the 6th week it was 10 %. The following 
week it was 8.33 %. In week 10 and 12 the infection rates were 21.43 % and 40 % 
respectively.
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Table 3.1 Number of infected cattle, number of cattle at risk, infection rate and 
cumulative number of infections in Group 1 and Group 2.
Days post treatment
Group - 14 0 14 28 42 56 70 84
Number I 13 NS 0 0 0 1 4 5
infected II 6 2 6 2 2 6 8
Number at I 35 66 33 33 33 30 33 27
risk II 31 27 28 20 24 28 20
Infection I 37.14 66 0 0 0 3.33 12.12 18.42
rates (%) II 19.35 7.41 21.43 10 8.33 21.43 40
Cumulative I 66 0 0 0 1 5 10
total II 2 8 10 12 17 19
number of
infections
Group I: Cattle treated with 1.0 mg isometamidium per kg body weight.
Group II: Cattle not treated with isometamidium 
NS: No sample
The mean isometamidium concentrations in the sera of the cattle in Group 1 rose to 
maximum values two weeks after treatment (Table 3.2 and Fig 3.1) and thereafter started 
to drop gradually. Drug was still detected in the sera up to the end of the trial (week 12). 
Isometamidium concentrations in the sera of individual cattle at the time break-through 
trypanosome infections occurred are shown in Table 3.3. Out of 10 infections 6 occurred 
in cattle in which circulating concentrations of isometamidium were detectable by the 
ELISA (limit of detection 0.2 ng/ml of serum). Three infections were detected in cattle 
that had serum drug levels below the lower limit of detection. No serum samples was 
available for one animal (No 623) at the time it was found to be infected with 
Trypanosoma congolense ( day 84), hence no conclusion could be reached regarding the 
drug sensitivity of these trypanosomes (Appendix 6).
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Table 3.2 Mean isometamidium concentration (ng/ml) in the sera of treated cattle. SD: 
Standard deviation.
Days post treatment
- 14 14 28 42 56 70 84
Average 0.379 2.059 0.943 0.619 0.404 0.416 0.358
+ SD 0.308 0.863 0.396 0.405 0.365 0.301 0.287
Median 0.274 1.961 0.841 0.496 0.305 0.296 0.275
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Table 3.3 Drug concentrations on days breakthrough infections were detected. ND =_not 
detected. NS = No sample. * = resistant.
Animal no Day post 
treatment
Buffy coat 
thick/thin
Isometamidium
concentration
ng/ml
Resistant
889 70 Tc ND
884 56 Tc 0.336
884 70 Tc 0.221
612 84 Tc ND
247 84 Tc ND
614 70 Tc 0.376
617 84 Tc 0.251
645 84 Tc 0.212
623 84 Tc NS
625 70 Tc 1.288 *
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Figure 3.1 Mean concentration of isometamidium (ng/ml) in sera of treated cattle at 
North Nyamphande, Zambia. The vertical bars represent the range of the standard 
deviation. T indicates day when the cattle were treated with isometamidium
10.00
.00 - -
0.10
-14 14 28 42 56 70 84
Time post treatment (Days)
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The average PCV of the cattle in the isometamidium group increased after they were 
treated with isometamidium (Tables 3.4a, and Fig 3.2). PCV of infected animals were 
generally below 25% (Table 3.4b, 3.4c).
The PCVs of animals in Group 1 changed significantly over time (P < 0.05). The same 
was observed in the control group (P < 0.05). PCVs did not differ significantly between 
the two groups (P > 0.05).
Table 3.4a The mean PCV (%) of the cattle in the treatment group and control group. 
SD: Standard deviation.
Days post treatment
Group - 14 + 14 28 42 56 70 84
Group 1 25.09 28.06 29.19 30.12 27.93 27.82 24.87
+ SD 5.32 3.56 3.76 2.93 4.33 3.17 4.22
Group 2 28.67 30.56 29.67 29.35 28.46 27.60 26.42
+ SD 3.98 3.29 4.20 3.85 3.80 4.93 4.64
Table 3.4b The individual PCV (%) of cattle in Group 1 on the day of breakthrough 
infection.
Animal no Day of break­
through 
infection
PCV (%) Animal no Day of break­
through 
infection
PCV (%)
889 70 26 612 84 32
884 56 23
884 70 28
247 84 23
614 70 31
617 84 17
645 84 20
625 70 22
623 84 19
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Table 3.4c The individual PCV (%) of cattle in Group 2 on the day of breakthrough 
infection.
Animal no Day of break­
through 
infection
PCV (%) Animal no Day of break­
through 
infection
PCV (%)
640 84 30 624 84 28
249 28 15 882 56 24
427 28 33 887 14 34
427 84 28 887 84 15
241 70 29 642 28 24
616 56 31 248 14 31
616 84 18 248 70 15
618 42 30 248 84 18
867 42 31 620 70 24
861 70 29 242 70 30
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Figure 3.2 The mean PCV (%) of the cattle in the treatment group and control group. 
Vertical bars shows range of standard deviation. T indicates the day cattle were treated 
with isometamidium.
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3.4 DISCUSSION
Drug resistance has become a major problem in the control of animal trypanosomiasis. 
There has been an increasing number of reports of trypanocide resistance in sub-Saharan 
Africa in recent years (Chitambo et al., 1992; Peregrine, 1994; Joshua, 1995). Incorrect 
strategy i.e. irregular treatment or prolonged intervals between treatments and 
underdosage of the trypanocidal drugs are some of the major causes of the apparent drug 
resistance of trypanosomes in the field (Connor, 1989). Assays to assess drug resistance 
in animal trypanosomes are required for use at the herd or area level that will allow 
veterinary personnel to advise field staff as to which of the few trypanocidal drugs should 
or should not be used for the control of trypanosomiasis in those areas where particular 
drugs seem to lose their curative or prophylactic activity (Kaminsky, 1990). Regular 
monitoring of the prevalence of drug resistance in the field remains a problem as methods 
used to monitor drug resistance lack sensitivity and most of them are neither field 
applicable nor widely available.
Although the mouse sensitivity test has been widely used to characterise the drug 
resistance of trypanosomes populations, it has been criticised because extrapolation of 
drug sensitive data from small to large animals is not possible due to inconsistencies 
between results obtained in small animals and in large animals (Sones et al, 1988). In 
addition, the mouse sensitivity test may take a long time and not all field isolates develop 
in them. In vitro methods generally require considerable laboratory equipment and 
therefore they cannot be conducted easily in many African laboratories. There is also the 
problem that some isolates are slow to adapt to in vitro cultivation and selection may 
occur during the adaptation process.
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The use of the drug ELISA to determine drug concentrations in the sera of treated 
animals has been demonstrated (Eisler et al, 1993, 1996). This assay has proved to be 
reliable in measuring drugs levels in the sera of treated cattle where concentrations of the 
drug as low as 0.2 ng/ml of serum can be detected by using this method. If the levels of 
drug in these treated animals are related to the occurrence of breakthrough infections, 
the ELISA could be used to distinguish between drug resistance and inadequate 
treatment.
In this field trial it was evident from the ELISA results that drug levels in individual 
traditional village cattle treated under field conditions could be measured successfully 
using the sequential saturation drug ELISA. It was also shown that when used together 
with the buffy coat technique and the thin and thick blood smears technique for 
parasitological examination, evidence of potential drug resistance could be obtained.
Eisler et al (1994) used the drug ELISA technique to determine the concentration at 
which three isolates of T.congolense which possessed different levels of resistance to 
isometamidium broke through in Boran cattle that were treated with isometamidium at 1 
mg/ml body weight. They found that isolates which were highly resistant (IL 3893) and 
moderately resistant (IL 3889) broke through when the mean drug concentration in the 
serum of cattle was 6.1 ng/ml (range 2.8 ng/ml - 12 ng/ml). The mean drug concentration 
in serum of cattle infected with a susceptible isolate (IL 1180) at the time of the 
breakthrough was not determined, but the mean drug level one month before the first 
infection ( 1 out of 5 cattle) was 0.7 ng/ml (range 0.5 ng/ml - 0.89 ng/ml). If the half life 
( Un) for the drug was calculated at 23.9 days in their experiment then by the time the 
first infection was detected the mean drug level might have been around 0.35 ng/ml
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(range 0.25 ng/ml - 0.44 ng/ml). If IL 1180 is not the most isometamidium-sensitive 
population that has been described (Peregrine et al, 1991) then the most sensitive 
trypanosome isolate may be cleared at concentration even lower than the one eliminating 
IL 1180. Eisler et al (1994) concluded that trypanosomes occurring in the presence of 
serum concentration of > 6 ng/ml are highly resistant and those occurring in the 
presence of concentration between 0.75 ng/ml and 6 ng/ml are moderately resistant.
Recently Eisler et al., (1996) carried out an experiment to determine the relationship 
between serum concentrations of isometamidium in Boran cattle and protection against 
tsetse-transmitted challenge with IL 1180 a drug-sensitive clone and a cloned population 
of T. congolense that posssessed a moderate level of resistance to isometamidium. They 
concluded that trypanosomes occuring in cattle with serum isometamidium concentration 
of 2.0 ng/ml may be considered at least moderately drug-resistant and at concentrations 
between 0.4 and 2.0 ng/ml a low level of drug-resistance.
According to the observations made by Eisler et al., (1994, 1996) using IL 1180 the 
serum drug level that can eliminate susceptible trypanosome populations is from 0.4 
ng/ml and above.
In the experiment carried out in Zambia the mean drug concentration at three months 
was 0.358 ng/ml. The result of the experiment in Zambia indicated that 1 out of 10 
(10%) of the population of Trypanosome congolense possess at least moderate 
resistance at serum drug concentration of above 0.6 ng/ml. Unfortunately the drug 
sensitivity of this isolate could not be confirmed in mice or experimental cattle.
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Overall, there were 10 trypanosome infections detected during the 12 week period 
following isometamidium administration. Twenty-six (26) infections occurred in 
untreated control cattle over the same period. Some untreated control cattle were found 
to be infected at every fortnightly sampling, whilst no isometamidium treated cattle were 
found to be infected during the first 6 weeks. Thereafter, one animal became infected 
over the following fortnight. Four more animals became infected over weeks 9 - 1 0  and 
5 more became infected over weeks 11 -12.
The severity of anaemia which follows infection is affected by several factors such as the 
virulence of the species of trypanosomes and host factors such as age, nutritional status 
and breed (Murray and Dexter, 1988). In the present experiment the PCV’s of the 
infected animals at the time of breakthrough infection were generally lower than those of 
the animals that were not infected. After treatment PCV’s of the infected animals 
increased.
In conclusion, it is possible to determine drug levels in many samples from field treated 
animals within a short time, and use these data for monitoring drug resistance. Unlike the 
technique of inoculation and treatment of mice in which only rodent infective 
trypanosomes can be evaluated, this technique deals with all species of trypanosomes, 
including Trypanosoma vivax which is not usually infective for mice. The results of this 
experiment showed that there was no evidence of drug-resistant trypanosomes at North 
Nyamphande.
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Chapter 4
Evaluation of the prophylactic effect of the slow release device 
containing homidium bromide in cattle under field conditions
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INTRODUCTION
Homidium bromide (Ethidium®; CAMCO) is commonly administered to cattle at a 
dose rate of 1 mg/kg body weight to treat trypanosomiasis. At this dose rate in cattle it 
has been shown to have prophylactic activity varying from two to nineteen weeks 
against tsetse field challenge (Leach et al., 1955 ; Dolan et al., 1990, 1992). The 
duration of prophylaxis depends primarily on the dose of the drug administered and the 
strain and species of parasite (Kinabo et al., 1988).
Several of the few trypanocides that are currently used to control trypanosomiasis in 
domestic animals produce local toxicity at the injection sites (Peregrine, 1994). Further 
more, many of these drugs offer only a short period of prophylaxis. In order to prolong 
prophylactic activity and reduce local toxicity at the injection sites produced by these 
drugs, different formulations (carrier or delivery systems) have been produced and 
evaluated. These include: Suramin complexes, dextran complexes, liposomal 
formulations, carrier erythrocytes and homidium and isometamidium polymers 
(Peregrine, 1994).
In order to determine whether the period of prophylactic effect of homidium bromide 
could be extended by incorporating the drug into a biodegradable slow release device 
(SRD) a polymer-drug complex was administered using a special needle and syringe, 
by the subcutaneous route above the shoulder region into the cattle.
The present study was carried out to test the prophylactic effect of the SRD at 1 
mg/kg body weight in cattle under field challenge in Zambia and compare it with the
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classical treatment of homidium bromide (Ethidium®) at 1 mg/kg body weight and 
isometamidium chloride (Samorin®) 1 mg/kg body weight given intramuscularly. The 
homidium-detection ELISA was used to measure serum drug levels in cattle given 
slow release devices and in those given by intramuscular injection. Isometamidium 
serum levels were measured by the isometamidium-detection ELISA (Table 4.3).
MATERIALS AND METHODS
Drugs
A cylindrical polymeric slow release device (polymer type: Rg 203, length 20-30 mm, 
diameter 3 mm, weight 50-75 mg) containing 25% Ethidium and 0.5% dexamethasone 
was developed and supplied by the University of Ghent, Department of Organic 
Chemistry, Section of Polymers. Preparation of SRD rods was by extrusion of a 
mixture of polyester and homidium bromide. This was done by adding homidium 
bromide to the solution of polyester in chloroform (CH2CI2) and stirring for 24 hours. 
Films were then casted and dried under vacuum. Rods were prepared by extrusion of 
these films at melting temperatures (160°C).
Intramuscular injectable isometamidium chloride (Samorin®, Rhone-Merieux, France) 
was purchased locally and homidium bromide (Ethidium®, CAMCO) was supplied by 
the Central Veterinary Research Institute, Zambia.
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Study area
The study was conducted at Chipopela Field Research Station, Katete District, Eastern 
Province of the Republic of Zambia. This station is used as a tsetse monitoring site by 
the Regional Tsetse and Trypanosomiasis Control Programme (RTTCP) in Zambia. 
The station lies between the latitude of 31° 50' E and 32° E and Longitude of 13° 45' 
S and 14°S and about 45 Km into the north-western part of Katete district. The area 
consist of miombo and mopani woodlands and lies in an area where Glossina morsitan 
morsitan and Glossina pallidipes occur (RTTCP Annual Report, 1995).
Animals
Two weeks before the trial commenced, 81 traditional Agoni (Sanga type) cattle were 
screened for trypanosome infection. A total number of 33 cattle were diagnosed 
positive for trypanosomes on both the buffy coat wet smears and Giemsa stained thin 
and thick blood smears. This revealed an infection rate of 40.74%. The average PCV 
was 24.62%. All the 81 cattle were eartagged, weighed and treated with diminazene 
aceturate (Berenil®; Hoechst) at a dose rate of 7 mg/kg live body weight.
The cattle were traditionally managed and grazed communally on natural pasture on 
free range in the tsetse infested area. No supplements were given to them. The farmers 
brought their cattle once every month for sampling.
Experimental design
At the beginning (day 0) of the trial 76 cattle were screened for trypanosomes and 
divided into four groups and treated according to their groups. All the cattle examined
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were negative for trypanosomes on both the buffy coat wet smears and the thick and 
thin dry blood smears.
Group one Cattle in this group received ethidium in the form of a slow release device 
(SRD) at a dose of 1 mg/kg live body weight. These implants were injected 
subcutaneously in the shoulder region using a special SRD needle and syringe (Plate 
lb). There were 16 cattle in this group.
Group two Cattle in this group received a dose of 1 mg/kg of isometamidium chloride 
by intramuscular injection (Plate la). There were 20 cattle in this group.
Group three This group received homidium bromide at a dose rate of 1 mg/kg by 
intramuscular injection. There were 20 cattle in this group.
Group four  This was a control group of 20 cattle that received no treatment.
The animals were exposed to natural challenge and grazed communally on free range. 
Diminazene aceturate, at a dose rate of 7 mg/kg was used to treat any animal that 
became positive for trypanosomes during the course of the experiment.
A weighband (Dalton, U.K.) was used to estimate the weight of the animals.
Parasitological examination and packed cell volume monitoring
Cattle were screened for the presence of trypanosomes once every month. Blood 
samples were collected into two heparinized capillary tubes (Hawksley, U.K.) from
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Plate 1. Administration of trypanocides in the field;
a) Intramuscular injection of homidium
b) Subcutaneous injection of a slow release device (SRD) containing 
homidium.
each animal from the ear vein and filled to about 10 mm from the top of the tubes. One 
tube was sealed immediately with cristaseal® (Hawksley, U.K.) and spun down in a 
microhaematocrit centrifuge (Hawksley, U.K.) for 5 minutes for packed cell volume 
(PCV) estimation and buffy coat examination. The second capillary tube was used for 
making thick and thin blood smears (Plate 2) and also acted as a spare in case of spin­
out or breakage during spinning down of the first tube in the centrifuge. After making 
the thick and thin smears the spare tube was sealed and held in a clearly labelled 
capillary tray.
After spinning the tubes for 5 minutes in the centrifuge the PCV were read using the 
micro-haematocrit reader (Hawksley, U.K.). After reading the PCV the capillary tubes 
were cut with a diamond pencil 2 mm below the buffy coat and wet blood smears made 
on the slides.
The buffy coat wet smears were examined using the buffy coat wet smear techniques 
of Murry et al., (1977) at the crushpen. The thin smears were fixed in methanol and 
later on together, with the thick smears, stained with 10% solution of Giemsa stain, 
dried and examined for the trypanosomes.
Serum sampling
Each month, blood from the jugular vein of each animal was collected into plain 
vacutainer tubes (Becton Dickson and Company, USA). Time was allowed for the 
blood to clot at ambient temperature. Sera was separated from the clotted blood after 
spinning in the centrifuge into 2 ml cryogenic vials (Alpha Labs, U.K). Sera in the
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Plate 2. Preparation of thick and thin blood smears in a field laboratory.
cryogenic vials were then stored in the freezer at - 20°C prior to analysis for drug 
concentrations.
Serum Drug Concentrations
A sequential saturation ELISA was used to determine the concentration of 
isometamidium and homidium in the sera.
This ELISA is fully described in Chapter Two.
Assessment of the sensitivity of isolates of Trypanosoma congolense to 
Isometamidium chloride and Homidium bromide in mice
Two isolates of Trypanosoma congolense obtained from cattle that were in the 
experiment, were tested in mice using the protocol as followed by Sones et al, (1988). 
Isolate CHOI was collected in December 1994 before the start of the experiment and 
isolate CH 542 in March 1995 when the first infections in cattle in the SRD group 
were observed. They were isolated from the cattle directly into mice and later on 
stabilates were made from the infected mice and stored in liquid nitrogen for further 
use.
In the procedure, Swiss mice were inoculated intraperitoneally with 0.2ml of diluted 
blood containing approximately 1 x 105 trypanosomes. A Neubauer counting chamber 
was used to count the live trypanosomes that were innoculated into the mice. 
Phosphate buffered saline with glucose (P.B.S.G pH 8.0, ionic strength 0.145) was 
used to dilute the blood.
Monitoring of blood by wet film preparations from the tail of mice followed every day 
until trypanosomes were detected. The mice were then treated with drugs
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intraperitoneaUy as per treatment group (Table 4.7). After treatment they were 
monitored every day during the first week and then once every week for 90 days. 
Isolate CHOI was assessed at the CVRI in Zambia and CH 542 at ILRI in Kenya.
Monitoring of density of tsetse flies
Both traps and Black Screen Man Fly Rounds (BFR) were used to monitor fly density. 
Epsilon traps (Plate 3) each baited with acetone released from standard 0.5 litre brown 
glass bottles without a lid, plus 2 sachets of phenol were placed in the infested area 
where the animals under the experiment grazed. For fly rounds, a black screen cloth 2 
x 1 metre suspended from a bamboo stick on the shoulders of two men was used 
(Plate 4). The black screen was baited with acetone in a 0.5 litre brown bottle without 
a lid and two sachets of phenols in two pockets on it. The two men walked and 
stopped at 200 metre (200 steps) intervals for 3 minutes and caught flies which rested 
on the screen and those following them in their vicinity with a hand net. The walking 
was done on permanent fly round routes in the grazing area. The fly rounds were done 
in the morning and afternoon every day.
Monitoring of the fly density started in December 1994 and ended in June 1995. This 
covered both rainy and dry seasons. The rainy season occurred from December to 
April and the dry season from May to June.
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Plate 3. An Epsilon trap in the grazing area.
Plate 4. Preparing for a Black Screen Man Fly Round.
RESULTS
Parasitaemia
In the SRD homidium group the first infections (3 animals out of 16) in the group were 
observed two months after treatment. More than 50% of the infections were observed 
in the fourth month after treatment. In the group of cattle given i.m. isometamidium 
the first infections (4 out of 20 animals) were revealed two months after treatment and 
by the third month after treatment more than 50% of the animals were infected. In the 
group given i.m homidium the first infections (10 out of 20 = 50%) were observed in 
the second month after treatment. In the control group 8 out of 20 animals were 
positive one month after the beginning of the study and by the second month 50% of 
them were positive (Table 4.1a and Table 4.1b).
Table 4.1a Cumulative total number of positive animals in group 1 (SRD-homidium), 
group 2 (i.m. isometamidium), group 3 (i.m. homidium) and group 4 (control) months 
post treatment.
Mont is post treatment
Group 0 1 2 3 4 5 6
1 0 0 3/16 7/16 10/16 12/16 12/16
2 0 0 4/20 10/20 12/20 12/20 14/20
3 0 0 10/19 16/19 17/19 17/19 17/19
4 0 8/20 10/20 16/20 17/20 18/20 18/20
Table 4.1b Cumulative number of positive animals (%) in group 1 (SRD-homidium), 
group 2 (i.m. isometamidium), group 3 (i.m. homidium) and group 4 (control) months 
post treatment.
Months post treatment
Group 0 1 2 3 4 5 6
1 0 0 19 44 62 75 75
2 0 0 20 50 60 60 70
3 0 0 53 84 89 89 89
4 0 40 50 80 85 85 85
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When calculating infection rates for each month, the pre-patent period (time between 
the infective tsetse bite and appearance of trypanosomes in the blood of the animal 
about two-three weeks) was taken into account. Animals that were treated with 
diminazene (Berenil®) the previous month were excluded from infection rate 
calculations. This is because exposure to therapeutic drugs such as Berenil® is one of 
the factors that determines the length of this period (Stephen, 1966). Mean pre-patent 
period in sheep on a low protein diet is between 12 and 26 days (Katunguka- 
Rwakishaya et al. 1995). Animals found positive and not sampled the previous month 
were also not included in the calculation (Table 4.2a and Tables 4.2b) because it was 
not known whether the infections were acquired in the previous month or during the 
present month for which the infection rate had been calculated.
In cattle from the SRD ethidium group, the apparent average protection period was 
much longer than that of the group given homidium by intramuscular injection
Table 4.2a Number of positive cattle over number of cattle at risk, months post 
treatment. Group 1 (SRD-homidium), group 2 (i.m. isometamidium), 
group 3 (i.m. homidium) and group 4 (control).
Months post treatment
GROUP 1 2 3 4 5 6
1 0/16 3/16 4/13 4/10 5/8 0/4
2 0/15 4/20 6/12 1/9 2/10 1/5
3 0/19 10/19 6/9 1/5 0/4 1/4
4 8/20 2/11 11/18 1/7 2/16 0/16
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Table 4.2b Incidence rates (%) of the animals in the four groups, months post
treatment. Group I (SRD-homidium), group 2 (i.m. isometamidium), 
group 3 (i.m. homidium) and group 4 (control).
Months post treatment
Group 0 1 2 3 4 5 6
1 0 0 19 31 40 62 0
2 0 0 20 50 11 20 20
3 0 0 53 67 20 0 50
4 0 40 18 61 14 12 0
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Figure 4.1 Incidence rate (%) of the animals in the four groups. 1 is SRD-homidium 
group, 2 is isometamidium group, 3 is i.m homidium group and 4 is control group
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Inflammatory reaction
An inflammatory reaction at the SRD implantation sites was observed one month after 
treatment in more than 50% (9/16) of the animals. The nodules measured on average 
2-3.5 cm in width and 4-5 cm in length. They persisted until the third month after 
treatment (Plate 5).
Drug concentrations
The isometamidium concentrations are shown in Table 4.3 and Figures 4.3a and 4.3b. 
Isometamidium ELISA analysis showed that the drug levels in the group given 
intramuscular isometamidium reached maximum levels one month after treatment and 
by the third month after treatment the mean level had fallen to levels of almost 0.2 
ng/ml. In the SRD homidium group the drug levels reached a maximum level two 
months after treatment and then slowly fell until the fourth month after treatment. 
Levels of less than 2 ng/ml were detected in the fifth month after treatment in the SRD 
group . In the i.m. homidium group the maximum levels were detected one month after 
treatment and by the second month after treatment the levels were below the level of
0.2 ng/ml (Table 4.3 and Figures 4.3a, 4.3b). The ELISA showed that high levels of 
the drug were maintained above the minimal detectable level of 0.1 ng/ml (Eisler et al., 
1993) for the longest time in the animals in the SRD-homidium group and the 
isometamidium group.
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Plate 5. A nine month old calf showing an inflammatory reaction at the injection 
site in the shoulder region one month after subcutaneous administration 
of a SRD-homidium implant.
Table 4.3 Mean drug concentrations (ng/ml) per treatment group, months post 
treatment.
SRD-HBR = SRD-homidium, I.M ISMM = intramuscular Isometamidium 
IM HBR = intramuscular homidium. SD = Standard deviation. ND denotes drug 
not detected.
Months post treatment
Group 0 1 2 3 4 5 6
SRD-
HBR
0.264 0.394 0.806 0.374 0.300 ND ND
+ SD 0.276 0.153 0.245 0.133 0.091
IM
ISMM
0.347 1.242 0.580 0.236 0.375 ND ND
+ SD 0.405 0.59 0.305 0.114 0.369
IM
HBR
0.212 0.312 ND ND ND ND ND
+ SD 0.132 0.211
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Figure 4.3a Mean isometamidium concentration (ng/ml) of the cattle treated with 
intramuscular isometamidium, months post treatment. The vertical bar indicates the 
range of the standard deviation.
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Figure 4.3b Mean homidium concentrations (ng/ml) of the cattle treated with either
SRD-homidium ( ---------) or i.m homidium ( ________ ). The vertical bar indicate
the limit of the range of the standard deviation.
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Packed Cell Volume (%)
The packed cell volume (PCV) values increased following treatment in the three 
groups of animals that received homidium or isometamidium and then gradually went 
down as the number of infection increased (Table 4.4a, b, c and Figure 4.4). In the 
control group the values remained almost the same during the experiment (Table 4.4a, 
and Fig 4.4).
Table 4.4a Mean PCV (%) of the animals in the four groups, months post treatment. 
Group 1 (SRD-homidium), group 2 (i.m. isometamidium), group 3 (i.m. homidium) 
and group 4 (control).
Months post treatment
GROUP -1 0 1 2 3 4 5 6
1 26.07 29.41 28.31 31.56 30.25 25.71 22.27 30.71
+ SD 8.12 6.38 5.00 6.55 5.78 4.25 6.93 3.95
2 22.16 29.25 29.4 30.30 26.60 26.60 24.43 29.80
+ SD 3.70 2.86 3.36 3.26 4.39 4.05 5.32 5.16
3 25.72 27.9 32.05 30.63 31.30 24.17 27.60 30.20
+ SD 5.37 5.16 5.17) 5.52 8.06 7.70 3.91 3.70
4 25.68 29.19 25.8 30.11 26.30 24.82 25.72 29.16
+ SD 5.97 4.40 4.44 5.32 6.59 5.08 4.52 5.09
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Table 4.4b Individual PCV(%) and drug concentrations (ng/ml) of cattle in 
SRD-homidium group at the first detection of infection. ND denotes not detected and 
NS no sample. * denotes possible drug-resistance.
Animal
No
Tryps Months
post
treatment
PCV
(%)
Drug
cone
(ng/ml
Animal
No
Tryps Months
post
treatment
PCV
(%)
Drug
cone
(ng/ml)
535 Tc 2 31 0.476 208 Tc 4 24 0.373
532 Tc 3 20 0.442 210 Tc 3 29 0.4
533 Tc 4 24 0.240 542 Tc 2 29 NS
538 Tc 5 19 ND 696 Tv 5 22 NS
519 Tc 3 28 0.538* 539 Tc 3 24 0.244
543 Tc 3 22 0.301
207 Tc 2 35 1.116*
Table 4.4c Individual PCV(%) and drug concentration (ng/ml) of the cattle in 
isometamidium group at the first detection of infection. ND denotes not detected. 
* denotes possible drug-resistance.
Animal
No
Tryps Months
post
treatment
PC
V
(%)
Drug
cone
(ng/ml)
Animal
No
Tryps Months
post
treatment
PC
V
(%)
Drug
cone
(ng/ml)
223 Tv 3 21 ND 537 Tc 5 23 ND
245 Tc 3 17 ND 531 Tc 5 22 ND
229 Tc 3 28 ND 221 Tc 6 26 ND
674 Tc 3 21 0.250 201 Tc 4 23 0.226
548 Tc 2 26 0.362 248 Tc 2 27 0.362
545 Tc 3 27 0.535* 546 Tc 3 24 0.328
536 Tc 2 35 0.622* 540 Tc 2 23 0.214
Table 4.4d Individual PCV(%) and drug concentration (ng/ml) of the cattle in 
im-homidium group at the first detection of infection. ND denotes not detected.
Animal
No
Tryps Months
post
treatment
PCV
(%)
Drug
cone
(ng/ml
Animal
No
Tryps Months
post
treatment
PCV
(%)
Drug
cone
(ng/ml)
691 Tc 2 31 - 225 Tc 2 30 0.238
690 Tc 4 13 ND 209 Tc 2 28 ND
214 Tc 3 28 ND 217 Tc 2 35 ND
200 Tc 3 29 ND 239 Tc 3 35 -
692 Tc 3 18 ND 219 Tc 3 20 ND
212 Tc 2 27 ND 231 Tc 2 29 ND
673 Tc 3 18 - 216 Tc 3 21 ND
241 Tc 2 40 ND 236 Tc 2 28 0.201
222 Tc 2 24 ND
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Figure 4.4 Mean PCV (%) of the animals in the four groups, (A) animals that were 
given SRD-homidium (B) animals that were given isometamidium intramuscularly. (C) 
animals that were given homidium intramusculary (D) animals in the control group. T 
denotes time of treatment T denotes time of first detection of paraasitaemia.
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Body Weight
The mean body weight of the three treatment groups increased up to the third month 
after treatment and thereafter started to fall (Table 4.5 and fig 4.5) as the proportion of 
cattle with trypanosome infection increased.
Table 4.5 Mean body weight (kg) of the animals per treatment group, months post 
treatment. Group 1 (SRD-homidium), group 2 (i.m. isometamidium), group 3 (i.m. 
homidium) and group 4 (control).
Months post treatment
GROUP 0 2 3 4 5
1 209.29 228.56 241.87 230.71 228.18
+ SD 60.80 75.69 60.91 62.32 41.19
2 336.05 334.60 357.67 346.25 327.14
+ SD 76.76 61.27 75.09 56.23 59.02
3 339.00 329.58 351.58 328.33 374.00
+ SD 59.82 71.94 70.12 66.98 48.27
4 316.67 320.74 320.55 304.41 292.5
+ SD 53.87 44.55 53.77 54.25 56.31
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Figure 4.5 Mean body weights(kg) of the animals in the four groups, (A) animals that 
were given SRD-homidium (B) animals that were given isometamidium 
intramuscularly. (C) animals that were given homidium intramusculary (D) animals in 
the control group. T denotes time of treatment. T denotes time of first detection of 
parasitaemia.
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Tsetse monitoring
Tsetse monitoring results (Table 4.6 and Figure 4.6) showed high numbers of flies 
throughout the trial. There was slight drop in the number of flies caught in January 
1995 (month 0) and February 1995 (month 1 post treatment) because some traps were 
stolen by villagers. These traps were replaced towards the end of February 1995. It is 
also possible that the fall in numbers might have been caused by the more dispersed 
nature of the tsetse population in the rainy season (Nash, 1939).
Table 4.6 Tsetse fly catches in traps and on fly rounds in the area where the cattle 
grazed.
TRAPS BLACK SCREEN FLY 
ROUNDS
MONTH Glossina
morsitans
Glossina
pallidipes
Glossina
morsitans
Glossina
pallidipes
TOTAL
M F M F M F M F
DEC 94 
(Month -1
9 5 0 0 185 62 0 0 261
JAN 95 
(Month 0)
7 0 0 0 121 19 0 0 147
FEB 95 
(Month 1)
1 22 3 0 75 38 0 0 139
MAR 95 
(Month 2)
12 46 0 0 143 48 0 0 249
APR 95 
(Month 3)
39 142 0 0 138 70 0 0 389
MAY 95 
(Month 4)
32 114 0 0 109 72 0 0 327
JUN 95 
(Month 5)
32 155 0 0 24 27 0 0 242
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Figure 4.6 Total number of catches of flies per month in both the traps and on 
rounds.
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Drug sensitivity tests
Drug sensitivity tests on the two isolates of T. congolense in mice showed that CD50  
for isometamidium chloride was <0.01 mg/kg live body weight of the mouse. For 
homidium bromide it was 0.3 mg/kg live body weight whereas for diminazene 
aceturate was 5.8 mg/kg live body weight (Table 4.7).
Prepatent period
The mean prepatent period of CHOI was 5.5 (±0.51) days following the needle 
challenge and For CH 542 it was 2 (± 0) days.
Virulence and pathogenicity
All the mice (5/5) infected with CH01 and which had not received treatment (control 
group) died during the monitoring period. The mean number of days to death was 16 
(± 4.5) days. For CH 542 the mice were euthanised with CO2 immediately they became 
positive.
Response to treatment with isometamidium, homidium bromide and berenil
There was no relapse infection for CH01 after treatment with isometamidium at all the 
treatment dosages (0.01 mg/kg, 0.1 mg/kg, 1 mg/kg, 5 mg/kg and 10 mg/kg).
For CH 542 one out of six relapsed 24 days post-treatment with isometamidium at 
dose rate of 0.01 mg/kg. With homidium bromide, at 0.01 there was no effect whereas
i
| at 0.1 mg/kg three out of six relapsed six days post-treatment. In the diminazene 
aceturate group, four treated at 2  mg/kg, relapsed six days post-treatment and two did 
not respond to treatment (Table 4.7)
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Table 4.7 Allocation of mice to treatment groups and the response to the drugs.
Stock and isolate Doses (mg/kg) of
ISMM/HBR/
Berenil
No effect Temporary
clearance
cure
CHOI 10.0 0 0 5
Stock-ISMM 5.0 0 0 5
1.0 0 0 5
0.1 0 0 5
0.01 0 0 5
CH 542 2.0 0 0 6
Isolate-ISMM 0.1 0 0 6
0.01 0 1 5
CH 542 2.0 0 0 6
Isolate-HBR 0.1 3 3 0
0.01 6 0 0
CH 542 50 0 0 6
Isolate-diminazene 10 0 0 6
aceturate 2 2 4 0
Stock-ISMM: Original stock tested against ISMM 
Isolate-HBR: Breakthrough isolate tested against HBR 
Isolate-ISMM: Breakthrough isolate tested against ISMM 
Isolate-diminazene aceturate: Breakthrough isolate tested against diminazene
aceturate
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Discussion
The trial clearly showed that under field conditions a longer prophylactic period could 
be obtained by treating the cattle with homidium formulated into a slow release device 
(SRD). As demonstrated in this experiment a much longer protective period was 
offered to cattle treated with SRD than those treated with homidium given by 
intramuscular injection. In the cattle given homidium by intramuscular injection only 
47% (9/19) were protected by the second month after treatment but 81% (13/16) were 
still protected in the SRD group. Whereas 50% of cattle treated with homidium by 
intramuscular injection remained protected for less than two months, 50% of the cattle 
treated with SRD remained protected for almost four months after treatment. Cattle in 
the isometamidium group were protected for a longer time than the cattle treated with 
homidium by intramuscular injection but not as long as those treated with SRD. 
Isometamidium forms a depot after intramuscular injection which slowly releases drug 
(Kinabo and Bogan, 1988). This might be the reason why the prophylactic period of 
isometamidium was almost the same as the period offered by the homidium SRD.
Although the SRDs were coated with 0.5% dexamethasone to prevent tissue reactions 
at the sites, these did occur. It appears that there was direct contact between homidium 
in the SRD and the surrounding tissue. This could have caused variations in the 
| prophylactic effect in individual cattle (Geerts et al., 1993; Kageruka et al., 1996).
; There was less variation in the group of cattle treated with homidium given by 
intramuscular route. Variation was also observed in the group of cattle given 
isometamidium i.m. probably as a result of the inflammatory reaction that this drug 
causes at the injection site (Kinabo and Bogan, 1988).
Apart from inflammatory reaction at the implantation site of the SRD homidium no 
other side effects were observed in cattle that were given these implants. The 
inflammatory reaction at the implantation sites disappeared by the third month after 
treatment. There was no death associated with treating the cattle with SRD during or 
after administration of the implants.
The advantage of the SRD homidium is the protection period offered is much longer 
than in the case of an intramuscular injection using the same dose rate of 1 mg/kg and 
the implants can be easily removed from the implantation sites under the skin at 
slaughter. Homidium given by intramuscular injection cannot be removed from the 
muscles. Homidium is a mutagenic drug and because of this it is important to remove 
the drug before the meat is consumed (Geerts et al., 1993).
The trial also clearly demonstrated that drug detection ELISAs for isometamidium and 
homidium could be used to measure serum drug concentrations of treated cattle under 
field conditions (Appendices 7, 8 and 9). Drug concentration as low as the minimum 
detectable levels of 0.2 ng/ml were easily detected in the treated cattle that were in this 
field trial in Zambia. Using this ELISA it was possible to examine many samples at a 
time. In less than 2 hrs, 64 samples can be examined using this ELISA.
Using the sequential saturation ELISA, two (2) out of twelve (12) trypanosome 
infections that occurred in cattle that were given SDR-homidium were possibly 
moderately drug-resistant. These cattle had drug levels above 0.6 ng/ml at the time of
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breakthrough. In the group that was given isometamidium intramuscularly two out of 
14 trypanosome infections were considered moderately drug-resistant. This suggests 
that at Chipopela there are some trypanosome populations that are moderately 
resistance to homidium and isometamidium. In the group of cattle that were given 
homidium intramuscularly none of the trypanosome infections occurred in cattle with 
serum drug levels above 0.6 ng/ml.
Drug sensitivity tests in mice of the two isolates showed no resistance to 
isometamidium and homidium. However isolate CH 542 showed slight resistance to 
diminazene aceturate at the recommended single dosage rate for chemotherapy of 
3.5mg/kg. The minimum curative dose (CD5o) for the mice was calculated at 5.8 
mg/kg for diminazene aceturate.
On average in all the months during the trial more male flies were caught on fly rounds 
than in traps whilst more females were caught in traps than fly rounds. The results of 
this work agrees with the observations that were made by Bursell (1961a). Bursell 
observed that males’ attraction to moving objects brought them into contact with 
teneral females which were also attracted to moving objects. Teneral females were 
after food as they had not yet taken their first meal and also had not mated before.
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Chapter 5
Influence of the plane of nutrition 
on the duration of isometamidium prophylaxis in sheep.
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INTRODUCTION
Isometamidium chloride (Samorin®, May and Baker) is the major chemoprophylactic 
drug used in domestic ruminants. At a dose rate of 0.5 mg/kg body weight it has been 
shown to confer complete prophylaxis for as long as 4 months in sheep under field 
conditions (Griffin and Allonby, 1977a). Toro et al., (1983) showed that the 
protection afforded by isometamidium, at a dose rate of 1.0 mg/kg against 
experimental infection by T. vivax, in sheep was 195 days.
Several factors have been suggested to have a major effect on the duration of 
isometamidium prophylaxis in domestic rumiants. Variation in the length of 
chemoprophylactic protection in the field could result from factors such as dose of the 
drug and strain of the parasites (Holmes and Torr, 1988). Nutritional status, 
concurrent diseases and breed susceptibility or tolerance could also be factors of 
influence (Kinabo, 1988).
The objective of the present study was to investigate whether nutritional intake and 
body weight influence the duration of prophylaxis afforded by isometamidium. 
Changes in biochemical parameters such as urea, cholesterol, albumin and p- 
hydroxybutyrate were also examined following treatment and at the time of 
breakthrough infection.
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MATERIALS AND METHODS 
Experimental animals
Twenty (10 pairs of twins) healthy Blackface male lamb castrates, aged 6 months old, 
were purchased from a hill farm in the West of Scotland. After purchase they were 
dosed with a broad spectrum anthelmintic, Oxfendazole (Systamex®, Pitman-Moore 
Ltd) at a dose rate of 5 mg/kg body weight and transferred from the farm to Cochno 
Research Centre, They were also vaccinated against pasteurella with Heptavac-P® 
(Hoechst UK Ltd) at a dose rate of 2 ml per sheep. A booster dose was given 4 
weeks later. To prevent foot rot the hooves were trimmed and dipped in a 10 % w/v 
solution of Zinc Sulphate (Gold Hoof, Sheep Fair Products, Brecon).
Feeding and housing
The diet consisted of hay, straw and a mixture of concentrates (Table 5.1a). Straw 
was given only to animals assigned to the low plane diet. The concentrate was 
composed of a mixutre of:
1. Barley 967.5 kg/tonne FM
2. Calcium carbonate (CaC0 3 ) 10.0 “
3. Sodium chloride (NaCl) 10.0
4. Dicalcium phoshate (Ca2P 04) 10.0
5. Trace elements 2.5
Diets were mixed by hand and animals were given the rations as shown in Table 5.1a. 
Animals were fed in groups twice a day at 9:00 hr and 16:00 hr. The ration allowance 
of the high plane diet was 0.4 Kg of concentrate mixture and 0.7 Kg of hay per day.
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Sheep on the low plane diet were given 0.1 Kg of concentrate mixture, 0.35 Kg of 
hay and 0.35 Kg of straw per day. The mean nutrient intake for each group is 
presented in Tables 5.1b and 5.1c.
Table 5.1a Proximate analyses (g/kg DM) of dietary ingredients.
Barley cone Straw Hay
Dry matter (g/kg) FM 869.1 871.8 852.3
Crude protein 117.6 28.0 96.8
Crude fibre 42.8 456.3 347.8
Ether extract 10.3 13.6 15.3
Ash 48.0 43.8 54.3
GE (MJ/kg) 16.8 17.5 17.7
Table 5.1b Nutrients supplied g/d
Fraction High plane______ Low plane
DM 944.3 690.3
CP 98.6 47.6
CF 222.4 246.7
EE 12.7 9 .6
Ash 49.1 33.7
GE(MJ) 16.4 12.1
Table 5.1c Overall diet analyses g/kg DM
Fraction High plane Low plane
DM 100.0 100.0
CP 104.5 69.0
CF 235.5 357.4
EE 13.5 13.9
Ash 52.0 48.9
GE (MJ) 17.4 17.5
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Dietary treatments
1. Total diet analyses
The diets were designed in such a way that the levels of crude protein was 50% 
greater in the high plane diet (99 versus 48 g/d in the low diet). The gross energy 
supplied was also higher in the high plane diet than the low plane diet (16.4 MJ v 12.1 
MJ)
2. Intakes
Fibre intake (g/d) was designed to be similar in each group (220-250g crude fibre/d). 
Total dry matter and gross energy intake were 35% greater in the high feed animals.
Animals were housed in a large animal fly-proof isolation unit. The two groups of 
animals were housed separately in two large pens. Wood shavings were used as 
bedding.
Analyses of feed
Analyses of the feed were done using standard procedure set up by the Ministry of 
Agriculture, Fisheries and Food (MAFF, 1981).
All protein analyses were done using the Kjel-foss Automatic 16210 machine (A/S N 
Foss Electric, Denmark). Gross energy (GE) was measured using the automatic 
adiabatic calorimeter (GallenKamp, UK). Fibre analyses were conducted using the 
Fibretech Instrument (Tecator, Sweden). A muffle furnace (Gallenkamp, UK) at 
500°C was used to analyse ash content. Ether extract was analysed using the electric 
isomantle machine (Isopad Ltd, England).
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Trypanosome challenge of sheep
To challenge the sheep at monthly intervals after treatment, a population of 
Trypanosoma congolense IL 1180, known to be sensitive to isometamidium at an 
effective dose of 0.001 mg/kg body weight in cattle (Sones et al., 1988) was used. 
The inoculum given was raised in irradiated infected mice. Blood was obtained by 
cardiac puncture from the infected mice under deep anaesthesia at the peak of 
parasitaemia. Blood from the mice was pooled and the parasitaemia estimated by 
haemocytometer and diluted with phosphate buffered saline (PBS) containing 1.5% 
glucose at pH 8.0 to give a final concentration of 1 x 105 trypanosomes. This was 
given subcutaneously in the shoulder region as an inoculum of 2 ml. Viability and 
infectivity of the trypanosomes was also tested in irradiated mice by injecting the same 
inoculum intraperitoneally. At each monthly challenge two untreated control sheep 
were also inoculated to test the viability and infectivity of the trypanosomes.
Parasitological and Packed Cell Volume (PCV) monitoring
Blood samples were collected for parasitological and PCV examination three times a 
week. Animals were bled from the jugular vein into heparinized vacutainer tubes 
(Becton Dickinson and Co., USA). At the laboratory the blood was well mixed on a 
blood cell suspension mixture (Luckham Denley, U.K). Two capillary tubes were 
filled with blood from each vacutainer tube, sealed with cristaseal (Hawksley, UK) at 
one end and centrifuged for 5 minutes in the microhaematocrit centrifuge. PCV were 
read using the PCV reader (Hawksley, UK) and the mean of the two duplicate 
capillary tubes was recorded. The trypanosomes were detected by the darkground
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buffy coat method (Murray et al., 1977) and parasitaemia graded from 0 to 5 as 
described by Paris et al., 1982) as shown in table 5.3.
Table 5.3 Scoring method for estimation of parasitaemia by using darkground/phase 
contrast. Magnification = x400.
Score Trypanosomes per field Estimated parasitaemia 
(trypanosomes ml'1)
0 None <102
1+ 1 - 3 per preparation 102 - 103
2+ 4-10 per preparation 103- 104
3+ 1 per field 5 x 103 - 5 xlO4
4+ 2 -1 0  per field 5 x 104 - 4 x 105
5+ 10- 100 per field > 5 x 105
6+ > 100 per field > 5 x 106
Collecting of blood samples
Blood for serum was collected from the jugular vein from all the sheep into plain 
vacutainer tubes (Becton Dickinson and Co., USA ). The blood was allowed to clot 
and sera separated 24 hr later. This was done after the tubes were centrifuged at 3500 
rpm for 20 minutes at 4°C. Serum was removed and stored in the freezer at - 20 °C 
until required.
Serum drug concentration
Determination of the isometamidium serum concentration was conducted using the 
sequential saturation ELISA for isometamidium. This is a modified competitive 
enzyme immunoassay described by Eisler et al., 1996. The modified assay is fully 
described in Chapter Two.
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The concentrations were determined at 30 minutes, 1 hour, 2 hours, 4 hours, 24 
hours, 30 hours, 48 hours, 54 hours, 72 hours, 78 hours after treatment and thereafter 
once every week until the end of the experiment.
Biochemical assays
Serum albumin concentrations were measured by the standard BCG Succinate method 
using the Technicon Axon discrete-analyser (Bayer Diagnotics pic, Berkshire, UK). 
Serum cholesterol were estimated by the cholesterol oxidase method using the 
Technicon Axon discrete-analyser (Bayer Diagnotics pic, Berkshire, UK). Urea was 
measured by the urease endpoint method using the Technicon Axon discrete-analyser 
(Bayer Diagnotics pic, Berkshire, UK), p-hydroxybutyrate (BOHB) concentrations 
were measured by enzymatic method using the Cobas Mira discrete-analyser (Randox 
Laboratories, Ireland).
Body weights
The sheep were weighed once a week using a sheep weighing scale (Poldenvale Ltd, 
Williton, Somerset). This was done immediately after collecting blood from the 
animals.
Experimental design
Twenty (10 pairs of twins) Scottish Blackface Lambs were used in this study. They 
were divided into two groups (high plane diet group and low plane diet group) of ten 
animals each. One twin was allocated to the high plane (HP) diet group and the other 
twin was allocated to the low plane (LP) diet group. Animals were allowed to feed on
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their respective diets for four weeks before commencement of the experiment. During 
this time they were bled three time a week for PCV analyses. They were also weighed 
once a week. This provided baseline data and helped the animals to get used to being 
handled. After four weeks on their group diets, six animals from the high plane group 
(HPDT) and six animals from low plane group (LPDT) were treated intramuscularly 
in the neck region with isometamidium at a dose rate of 0.5 mg/kg body weight. Four 
animals from each group acted as untreated challenge controls (HPDC and LPDC).
A month after treatment the treated animals from the two groups and one untreated 
animal from each control group were inoculated with Trypanosoma congolense. 
Challenge was repeated once every month until all the drug-treated animals became 
positive.
Data analyses
Analyses of variance (Anova) on Minitab and Excel 5 programms were used to 
determine any variation or differences between the two groups. Values of P < 0.05 
were considered significant. Results are presented as means + standard error of mean 
(SEM).
RESULTS
Parasitological findings
The prophylaxis period offered to the sheep on the high diet was 121 + 14 days and 
that on a low plane diet was 117 + 11 days (Tables 5.4a and 5.4b). There was no 
significant difference in the prophylactic period (P > 0.05). The prepatent period of T.
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congolense (after the 4th challenge) in the sheep on a high plane diet was 13 + 3 days 
and that on a low plane diet was 12 + 4 days. There was no significant difference in 
these prepatent periods.
The mean prepatent period of the T. congolense in the challenged controls on a high 
plane diet was 8 + 2 days and of the controls on a low plane diet was 9 + 1  days 
(Table 5.4c and 5.4d) No significant difference was observed between the two 
groups.
Table 5.4a Prophylatic period offered by isometamidium to sheep challenged with T. 
congolense and given a high plane diet. (SD = Standard deviation. ND = not 
detected.)
Animal
No
Date of 
Samorin 
prophylaxis 
treatment
Day
detected
positive
Prophylactic
period
Number
of
challenge
after
which
they
became
positive
Days
after
challenge
Samorin
cone
(ng/ml)
PCV (%) 
at break­
through 
infection
440 12/03/96 10/07/96 112 4th 8 ND 25
446 12/03/96 19/08/96 140 5th 20 ND 25
450 12/03/96 16/07/96 112 4th 14 ND 24
458 12/03/96 7/08/96 140 5th 8 ND 32
482 12/03/96 16/07/96 112 4th 14 ND 27.5
488 12/03/96 16/07/96 112 4th 14 ND 28
A verage
SD
121 
(± 14)
13
(± 3 )
27
(±3)
Days of challenge 
1st = 9/4/96 
2nd = 7/5/96 
3rd = 4/6/96 
4th = 2/7/96 
5th = 30/7/96
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Calculation of prophylatic period:
This was the number of days from date of isometamidium chloride prophylactic 
treatment to the date of challenge that resulted into parasitaemia.
Table 5.4b Prophylatic period offered by isometamidium to sheep challenged with T. 
congolense and given a low plane diet. (SD = Standard deviation. ND = not 
detected.)
Animal
No
Date of 
Samorin 
prophylaxis 
treatment
Day
detected
positive
Prophylatic
period
Number
of
challenge
after
which
they
became
positive
Days
after
challenge
Samorin
cone
(ng/ml)
PCV (%) at 
break­
through 
infection
442 12/03/96 10/7/96 112 4th 8 ND 23
448 12/03/96 5/8/96 140 5th 6 ND 25.5
452 12/03/96 16/7/96 112 4th 14 ND 21
460 12/03/96 16/7/96 112 4th 14 ND 21.5
484 12/03/96 16/7/96 112 4th 14 ND 25.5
490 12/03/96 19/7/96 112 4th 17 ND 23.5
Average 117 12 23
SD (±11) (±4) (±2)
Table 5.4c The prepatent period (days) of T. congolense in challenge control sheep 
given a high plane diet. (SD = Standard deviation)
Animal
No
Day of 
needle 
challenge
No of 
challenge
Day
detected
positive
prepatent
period
Comment
454 9/4/96 1st 17/4/96 8 terminated on 
30/4/96
466 7/5/96 2nd 15/05/96 8 terminated on 
28/5/95
470 4/6/96 3rd 14/5/96 10 terminated on 
25/6/96
478 2/7/96 4th 8/7/96 6 terminated on 
6/8/96
Average 8
SD (±2)
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Table 5.4d The prepatent period (days) of T. congolense in the challenge control 
sheep given a low plane diet. (SD = Standard deviation)
Animal
No
Day of 
needle 
challenge
No of 
challenge
Day
detected
positive
prepatent
period
Comment
456 9/4/96 1st 19/04/96 10 terminated on 
30/4/96
468 7/5/96 2nd 15/05/96 8 terminated on 
28/5/96
474 4/6/96 3rd 14/06/96 10 terminated on 
25/6/96
480 2/7/96 4th 10/7/96 8 terminated on 
6/8/96
Average 9
SD (± D
Serum isometamidium concentration
The mean isometamidium concentration of the treated sheep on the high plane diet 
reached its maximum at 4 hours post treatment whilst that for the sheep on the low 
plane diet was 2 hours post treatment (Tables 5.5a, 5.5b and Figure 5.1). Thereafter 
the concentration started decreasing. The drug concentration was measurable up to 6 
weeks post treatment. After 6 weeks post treatment the drug concentrations were 
below the detection limit of 0.2 ng/ml of serum. There was no significant difference (P 
> 0.05) in the mean drug concentration values between the treated group on the high 
protein diet and the treated group on the low plane diet.
Table 5.5a Mean drug concentration (ng/ml) of the treated sheep on a high plane 
diet (HPDT) and on a low plane diet (LPDT) from zero to 144 hrs post treatment. 
(BT = Before treatment)
Hours post treatment
GROUP BT 1/2 1 2 4 24 30 48 54 72 78 144
HPDT 0.03 46.82 57.80 52.92 63.15 23.46 22.58 14.74 14.86 7.83 7.17 3.24
+ S.E.M 0.01 7.05 9.57 8.13 7.34 6.19 2.38 2.26 2.80 0.61 0.66 0.24
LPDT 0.03 64.80 71.62 78.60 60.81 27.75 22.97 11.78 9.96 8.31 7.34 3.40
+ S.E.M 0.01 20.12 21.79 19.20 8.20 4.59 2.83 0.30 0.77 0.84 0.34 0.19
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Table 5.5b Mean drug concentration (ng/ml) of the treated sheep on a high plane 
diet (HPDT) and on a low plane diet (LPDT) two to twenty-three weeks post 
treatment. (ND = Not detected)
Weeks post treatment
Group 2 3 4 5 6 7 8 9 10 11
HPDT 0.83 0.66 0.44 0.24 0.23 ND ND ND ND ND
+ S.E.M 0.12 0.17 0.08 0.04 0.03 ND ND ND ND ND
LPDT 0.91 0.57 0.37 0.23 0.19 ND ND ND ND ND
+ S.E.M 0.13 0.14 0.05 0.04 0.03 ND ND ND ND ND
Continuation of table 5.5b
Weeks post treatment
12 13 14 15 16 17 18 19 20 21 22 23
ND ND ND ND ND ND ND ND ND ND ND ND
ND ND ND ND ND ND ND ND ND ND ND ND
ND ND ND ND ND ND ND ND ND ND ND ND
ND ND ND ND ND ND ND ND ND ND ND ND
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Figure 5.1 Mean drug concentration (ng/ml) of the treated sheep on a high plane diet 
(HPDT) and on a low plane diet (LPDT). (a) from zero hour to 144 hrs post 
treatment (b) from 2 - 2 3  weeks post treatment, vertical bars show the limits of the
range of the standard error of the mean (SEM).
100 -r
100
Time post treatment (hours)
10 - ■
HPDT
LPDT
0.00 20.00 40.00 60.00 80.00 100.00 120.00 140.00
Time post treatment (Hours)
b
10.00 T
Echc
ocoo
E 1.002 R
-g V*
'E
&
©
EoW
0.10
5 62 3 4
Time post treatment (Weeks)
- O — HPDT 
—• — LPDT
130
Body weight
The mean body weight of the treated sheep (HPDT) in the high plane diet group was 
higher than that of the sheep on a low plane diet (Table 5.6 and Figure 5.2). This 
remained so throughout the experiment and was significantly different. The treated 
sheep on a high plane diet gained 4.25 kg between the beginning of the study and the 
week they became parasitaemic whilst those on a low protein diet lost 1.83 kg within 
the same period.
131
l 
+ 
S.E.M
 
|
IL
P
D
T
H*
CO
m
2
IH
P
D
T
| G
roup
ro COCO
00
JO
CO
CO
CO
o
i
Ok.
ro
CO
CO
CO
*00
ro
bi
CO
CO
o
1
CO
ro
CO
CO
CO
bi
ro
CO
CO
CO
CO 1ro
ro
Ok.
CO
CO ro
05
Ok.
o
CO
i
2.0
CO
ro
bo
JO
0 0
Ok.
o o
:>
0
CD
s r
2.3
CO
ro
O k
ro
b
Ok.
o
Ok.
T 3
O
Crt
JO
CO
o
0k.
CO
o
CO
00
CO ro
0
0
3
be
CO
o
CO
CO
CO
bi CO
3
CO
ro
05
00
CO
CO
00
o Ok.
CO
ro
CO
CO
CO
bi
CO
CO
o 05
CO
CO
o
CO
CO
CO
CO
o
ro
CO
ro
CO
bi
ro COCO
CO CO
ro
CO
CO
o
Ok.
CO
b
Ok.
b
ro
ro
CO
mU,
Ok.
to
j k .
b CO
ro
CO
CO
CO
Ok.
j k .
Ok.
co cn
ro
be
CO
05
cn
ro
Ok.
cn
b -v j
ro
■vi
o Ok.
CO
-v j
o
ro
o
ro
05
o
CO
b
ro
ro
r
n
3
cro^
N-J
so'&
o
H 00 ncr cn
p
3
O
a . bv
C- v- 1-9
o 3 zr3“
P 2. cecFT 3ce
p
O
3
09ce 3
c. 3
£ .
cr
0
3" c .
5: p v;
£
5 2 .
o a . 00*
o ce
3*
Oo 7^*
ce 7T(TO
O
£ O
P
- •  ceCTO . .
T5 re —  re ^ "3 
0) -  
C. re
ce' S  *■* re C-
E 3
T3 3*
D  -
|H So" 
w  o
S 3 H 2.
o  S  
*  S.
"O Cl
ST S'
§ 3
S: o  
S  La
132
Figure 5.2 Mean body weights of the sheep treated with isometamidium on a low 
and high plane d ie t. Vertical bars show the limits of the range of the standard error of 
the mean (SEM). T = point of breakthrough infection. T = point of treatment.
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Packed cell volume (PCV, %)
There was a significant difference (P < 0.05) between the PCV of the treated sheep on 
the high plane diet and the low plane diet. The PCV of the treated sheep on a high 
plane diet was higher than the PCV of the sheep on the low plane diet (Table 5.7 and 
Figure 5.4). There was a drop in the PCV after week 17, when the drug-treated 
sheep in both groups became parasitaemic.
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Figure 5.4 Mean PCV (%) of the treated sheep on low and high plane diet. Vertical 
bars show the limits of the range of the standard error of the mean (SEM).
T = point of breakthrouh infection. T = point of treatment.
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Serum cholesterol concentration
The mean cholesterol concentration of the sheep on a high plane diet was lower than 
the mean concentration of the sheep on the low plane diet throughout the experiment 
(Table 5.8, and Figure 5.5). This was statistically significant (P < 0.05).
Table 5.8 The mean cholesterol concentrations (mmol/L) of the treated sheep on a 
high (HPDT) and low plane diet (LPDT).
Months post treatment
Group -1 1 2 3 4 5
HPDT 2.04 1.91 2.11 2.26 2.20 1.76
+ SEM 0.11 0.11 0.07 0.10 0.12 0.16
LPDT 2.24 2.84 3.16 3.03 2.80 1.89
+ SEM 0.08 0.10 0.06 0.09 0.09 0.09
Cholesterol concentration showed a significant decrease in both the treated groups of 
the sheep after they became parasitaemic. This happened after the 4th month post 
treatment.
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Figure 5.4 Mean cholesterol levels (mmol/L) of the treated sheep on a low (LPDT) 
and high plane diet (HPDT). T = point of breakthrough infection. Vertical bars show 
the limit of the range of the standard error of the mean (SEM). T = point of treatment.
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Serum albumin
The mean serum albumin concentrations in treated sheep on the high plane diet 
increased from 30.17 + 0.48 g/L at one month post treatment to 33.67 + 0.24 g/L 
four months post treatment. At four months post treatment the animals became 
positive for trypanosomes and the concentration of albumin decreased in the sheep. 
The albumin levels decreased to 31.33 + 0.63 g/L (Table 5.9 and Figure 5.6). The 
mean serum albumin concentration in the treated sheep on the low plane diet showed 
an increase from 27.50 + 0.56 g/L one month post treatment to 30.50 + 0.37 g/L four 
months post treatment. A decrease in the mean albumin concentration was also 
observed in this group when they became positive for trypanosomes and at five 
months post treatment the mean concentration dropped to 27.60 + 0.52 g/L. The 
mean albumin concentration was higher in treated sheep on a high plane diet than 
those on a low plane diet and this was statistically significant (P < 0.05).
Table 5.9 Mean albumin concentrations (g/L) of the treated sheep on a high plane 
(HPDT) and low plane diet (LPDT).
Months post treatment
Group -1 1 2 3 4 5
HPDT 30.83 30.17 30.00 31.67 33.67 31.33
+ S.E.M 0.54 0.48 0.25 0.10 0.24 0.63
LPDT 28.67 27.50 27.50 28.67 30.50 27.60
+ S.E.M 0.62 0.56 0.17 0.30 0.37 0.52
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Figure 5.5 Mean albumin concentration (g/L) of the treated sheep on a high (HPDT) 
and low plane diet (LPDT). T = point of breakthrough infection. Vertical bars show 
the range of the standard error of the mean (SEM). T = point of treament.
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Urea concentration
The mean urea concentration of treated sheep on the high plane diet was higher than 
that of the sheep on the low plane diet. Statistically there was no difference (P >
0.05).
Table 5.10 Mean urea concentrations (mmol/L) of the treated sheep on a high plane 
(HPDT) and low plane diet (LPDT).
Months post treatment
Group -1 1 2 3 4 5
HPDT 2.77 3.98 4.53 5.90 4.73 9.40
+ S.E.M 0.07 0.21 0.33 0.16 0.04 0.11
LPDT 2.02 3.10 3.27 3.92 3.40 8.96
+ S.E.M 0.09 0.10 0.43 0.20 0.25 0.38
After the sheep became positive for trypanosomes the mean concentration of urea in 
both treated groups increased significantly. This occured between month 4 and month 
5 post treatment (Table 5.10 and Figure 5.8).
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Figure 5.6 Mean urea concentration (mmol/L) of the treated sheep on a high (HPDT) 
and low plane diet (LPDT). T = point of breakthrough. Vertical bars show the limit of 
the range of the standard error of the mean (SEM). T = point of treatment
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P-hydroxybutyrate (BOHB)
The mean concentration of p-hydroxybutyrate (mmol/L) fluctuated in both treated 
sheep on either high or low plane diet throughout the experiment (Table 5.11 and 
Figure 5.9). Statistically there was no significance difference (P > 0.05) in the 
concentration of BOHB between the sheep on the high diet and those on the low 
plane diet.
Table 5.11 Mean BOHB concentrations (mmol/L) of the treated sheep on a high 
plane (HPDT) and low plane diet (LPDT).
Months post treatment
Group -1 1 2 3 4 5
HPDT 0.33 0.23 0.30 0.27 0.35 0.30
+ S.E.M 0.01 0.01 0.02 0.02 0.01 0.01
LPDT 0.25 0.22 0.28 0.33 0.30 0.34
+ S.E.M 0.02 0.01 0.02 0.01 0.00 0.01
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Figure 5.7 Mean BOHB concentration (mmol/L) of the treated sheep on a high 
(HPDT) and low plane diet (LPDT). T = point of breakthrough infection. Vertical 
bars show the limit of the range of the standard error of the mean (SEM). T = point of 
treatment.
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DISCUSSION
In the present experiment nutritional intake and body weight had no influence on the 
isometamidium prophylaxis period in the sheep challenged with T. congolense. The 
mean prophylaxis period offered to the sheep on a high plane diet was 121 + 14 days 
while for the sheep on a low plane diet was 117 + 11 days. Nor was there an effect on 
the prepatent period to parasitaemia in both control groups. The prepatent period of 
the trypanosomes in the control group on the high plane diet was 8 + 2  days while 
those on the low plane diet was 9 + 1  day.
Diet had no influence on the isometamidium concentration in the sheep on either high 
plane diet or low plane diet. Statistically there was no difference (P > 0.05) between 
the mean drug concentration of the sheep on the high plane diet and that on the low 
plane diet, suggesting that pharmacokinetics were not influenced by the dietary level 
of protein and gross energy. The mean drug concentrations at the time of the 
breakthrough infection in both groups were below the lower limit of detection of 0.2 
ng/ml. This shows that the trypanosomes used in this experiment were not resistant to 
isometamidium. This is in agreement with the observation that was made by Sones et 
al., (1988). Results of their studies in cattle showed that the trypanosomes were 
sensitive to isometamidium at 0.001 mg/kg body weight.
The mean PCV of the animals on a high plane diet was higher than that of the sheep 
on a low plane diet indicating that dietary plane had some influence on the PCV 
values. Trypanosome infection also had an influence on the PCV values. After the
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breakthrough infections the mean values decreased in the sheep in both groups. 
Katunguka-Rwakishaya et al., (1992,1993) observed similar results in sheep given the 
high and low plane diet and infected with T. congolense.
Diet had an influence on the body weights. The mean body weight of the sheep on a 
high plane diet was higher than that of the sheep on a low plane diet and was 
statistically significant (P < 0.05) throughout the experiment. Body weight did not 
influence the prophylatic period of the sheep either on a high or low plane diet.
Diet had an influence on cholestrol levels. The levels of cholestrol of the sheep on the 
low plane diet was higher than that of the sheep on the high plane diet and was 
statistically significant (P < 0.05). Trypanosome infection did have an effect on the 
amount of cholesterol in the serum. When the animals became parasitaemic the levels 
of cholestrol dropped in both groups. Trypanosomes depend on cholesterol found in 
the blood of their host for their energy (Gillet and Owen, 1987). The appearance of 
the trypanosomes indicated that they were taking up the cholesterol for their energy 
requirements. In the treated animals on a high plane diet the mean concentration 
dropped from 2.20 mmol/L to 1.76 mmol/L one month after trypanosomes 
breakthrough. In the low plane group the concentration dropped from 2.28 to 1.89 
mmol/L within the same period.
There was a dietary effect on the concentration of albumin in the two treated groups. 
The high plane diet group had higher concentration of albumin than the low plane
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group. Trypanosomes had an effect on the concentration of albumin. When 
trypanosomes were detected, the concentration of albumin in both groups decreased.
Urea concentration in both treated groups remained statistically similar, suggesting 
that dietary intake did not influence the mean concentrations of urea. Trypanosome 
infection did have an influence on the concentration of urea. After breakthrough 
infection the urea concentration increased in both treated groups. This results 
suggests that protein catabolism was increased in the infected sheep. There was no 
dietary or trypanosome infection influence on the concentration of p-hydroxybutyrate. 
Throughout the experiment the mean values of p-hydroxybutyrate of the two groups 
fluctuated.
In conclusion this study has shown that the prophylactic period conferred by 
isometamidium is not influenced by the dietary intake of the sheep, despite dietary 
influences on PCV, body weight and the serum concentrations of urea, cholesterol 
and albumin concentrations.
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CONCLUSION
The competitive enzyme immunoassay using isometamidium-horseradish-peroxidase 
conjugate produced using n-hydroxysuccinamide and modification to the assay to a 
sequential saturation CEIA has proved to be a useful development to the assay for 
measuring isometamidium and homidium concentrations in sera of treated cattle and 
sheep. The ELISA also proved that in combination with other parasitological 
diagnostic methods it can be used as an indirect method for monitoring drug-resistant 
trypanosomes in treated animals.
Formulating homidium bromide into slow release devices (SRD) prolonged the 
prophylactic effect of homidium in the cattle kept under natural tsetse challenge, at 
Chipopela in Zambia. The homidium-SRD protected 50 % of the animals up to four 
months post treatment whereas 50 % of the animals given homidium by intramuscular 
injection were protected only up to two months post treatment.
The sheep experiment showed that the plane of nutrition had no effect on the duration 
of isometamidium prophylaxis, despite effects on the PCV, body weight, and serum 
concentrations of urea, albumin and cholestrol.
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RECOMMEDATIONS
1. From the results obtained in these studies it is recommended that the competitive 
enzyme immunosorbent assay (CEIA) in combination with other parasitological 
diagnostic methods be used to monitor drug resistance in the field.
2. The studies carried out at North Nyamphande and Chipopela showed that by the 
third month after treatment the serum levels of isometamidium are below 0.4 ng/ml. It 
is recommended that the intervals between drug administration be re-assessed and 
perhaps reduced.
3. Further work on the homidium-SRD is justified since the prophylaxis period of 
homidium may be usefully extended by such devices.
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Appendices
A p p e n d ix  1
Preparation of Phoshate buffered saline (PBS x 10) pH 7.4 for ELISA
1. Sodium chloride (NaCl) 80g
2. Sodium hydrogen phosphate (Na2HP0 4 ) 14.8g
3. Potassium hydrogen phosphate (KH2P 0 4) 4.3g 
Dissolve the above salts in llitre deionised water.
Appendix 2
Preparation of Phosphate buffered saline , pH 7.4, containing 0.05% Tween 20 
(PBST) for ELISA
This is prepared by mixing the following solution thoughly:
1. 900 ml of deionised water
2. 100 ml PBS X 10
3. 500 j l l I  of Tween 20
Appendix 3 
Preparation of washing buffer pH 7.4 for ELISA
1. 4.9 litres of deionised water
2. 100 ml of PBS x 10
3. 2.5 ml of Tween 20
Mix the above solutions throughly in 5 liter container.
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A p p e n d ix  4
Optical densities (OD) wavelength (absorbances at 450 nm) of 24 individual sera from 
untreated Zimbabwe Mashona cattle, obtained using sequential saturation assay.
Plate A.
ID OD
la
OD
lb
OD
2a
OD
2b
Mean
1
Vars 1 Mean
2
Vars 2 Mean
1&2
Vars
1&2
P324 1.098 1.041 1.126 1.016 1.070 0.00162 1.071 0.00605 1.070 0.00000
P274 1.103 1.033 1.143 1.050 1.068 0.00245 1.097 0.00432 1.082 0.00041
T523 1.150 1.134 1.149 1.077 1.142 0.00013 1.113 0.00259 1.128 0.00042
T391 1.147 1.017 1.232 1.121 1.082 0.00845 1.177 0.00616 1.129 0.00447
P225 1.176 1.114 1.153 1.106 1.145 0.00192 1.130 0.00110 1.137 0.00012
P336 1.179 1.160 1.208 1.079 1.170 0.00018 1.144 0.00832 1.157 0.00034
P272 1.192 1.247 1.094 1.132 1.220 0.00151 1.113 0.00072 1.166 0.00567
P242 1.205 1.218 1.153 1.118 1.212 0.00008 1.136 0.00061 1.174 0.00289
T478 1.214 1.078 1.233 1.179 1.146 0.00925 1.206 0.00146 1.176 0.00180
P238 1.262 1.144 1.205 1.135 1.203 0.00696 1.170 0.00245 1.187 0.00054
J156 1.245 1.192 1.236 1.129 1.219 0.00140 1.183 0.00572 1.201 0.00065
P306 1.212 1.218 1.223 1.153 1.215 0.00002 1.188 0.00245 1.202 0.00036
P239 1.228 1.178 1.212 1.193 1.203 0.00125 1.203 0.00018 1.203 0.00000
BC 1.246 1.227 1.244 1.194 1.237 0.00018 1.219 0.00125 1.228 0.00015
P317 1.231 1.179 1.316 1.208 1.205 0.00135 1.262 0.00583 1.234 0.00162
P221 1.335 1.265 1.235 1.125 1.300 0.00245 1.180 0.00605 1.240 0.00720
P236 1.341 1.255 1.191 1.206 1.298 0.00370 1.199 0.00011 1.248 0.00495
P243 1.316 1.250 1.246 1.214 1.283 0.00218 1.230 0.00051 1.257 0.00140
J437 1.321 1.255 1.274 1.210 1.288 0.00218 1.242 0.00205 1.265 0.00106
194 1.356 1.228 1.283 1.198 1.292 0.00819 1.41 0.00361 1.266 0.00133
P228 1.272 1.349 1.235 1.251 1.311 0.00296 1.243 0.00013 1.277 0.00228
P229 1.346 1.284 1.247 1.250 1.315 0.00192 1.249 0.00000 1.282 0.00221
P235 1.308 1.308 1.313 1.253 1.308 0.00000 1.283 0.00180 1.296 0.00031
ID = Identity of the animal OD = Optical densities Vars = Variances
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A p p e n d ix  5
Optical densities (OD) wavelength (absorbances at 450 nm) of 24 individual sera from 
untreated Zimbabwe Mashona cattle. Plate B.
ID 1OD
la
OD
lb
OD
2a
OD
2b
Mean
1
Vars 1 Mean
2
Vars 2 Mean 1 
& 2
Vars 
1 & 2
P306 1.067 1.083 0.934 0.979 1.075 0.00013 0.957 0.00101 1.016 0.00702
T523 1.114 1.023 1.034 0.934 1.069 0.00414 0.984 0.00500 1.026 0.00357
P324 1.104 1.104 1.027 0.996 1.094 0.00022 1.012 0.00048 1.053 0.00336
P272 1.072 1.107 1.086 0.996 1.090 0.00061 1.041 0.00405 1.065 0.00118
P336 1.107 1.067 1.070 1.038 1.087 0.00080 1.057 0.00051 1.071 0.00054
P239 1.160 1.171 1.051 1.027 1.166 0.00006 1.039 0.00029 1.102 0.00800
P274 1.147 1.172 1.086 1.035 1.160 0.00031 1.061 0.00130 1.110 0.00490
P242 1.145 1.155 1.087 1.063 1.150 0.00005 1.075 0.00029 1.113 0.00281
P243 1.094 1.204 1.104 1.101 1.149 0.00605 1.103 0.00000 1.126 0.00108
H196 1.177 1.115 1.124 1.087 1.146 0.00192 1.106 0.00068 1.126 0.00082
P236 1.172 1.154 1.091 1.091 1.163 0.00016 1.091 0.00000 1.27 0.00259
P317 1.189 1.181 1.089 1.063 1.185 0.00003 1.076 0.00034 1.131 0.00594
P225 1.230 1.109 1.164 1.042 1.170 0.00732 1.103 0.00744 1.136 0.00221
BC 1.114 1.156 1.154 1.137 1.135 0.00088 1.146 0.00014 1.140 0.00006
J156 1.234 1.130 1.116 1.089 1.182 0.00541 1.103 0.00036 1.142 0.00316
P238 1.203 1.198 1.048 1.130 1.201 0.00001 1.089 0.00336 1.145 0.00622
P221 1.223 1.205 1.108 1.093 1.214 0.00016 1.101 0.00011 1.157 0.00644
P228 1.211 1.203 1.198 1.061 1.207 0.00003 1.130 0.00938 1.168 0.00300
P235 1.199 1.182 1.154 1.141 1.191 0.00014 1.148 0.00008 1.169 0.00092
J437 1.258 1.136 1.160 1.130 1.197 0.00744 1.145 0.00045 1.171 0.00135
194 1.234 1.242 1.191 1.145 1.238 0.00003 1.168 0.00106 1.203 0.00245
P229 1.291 1.286 1.200 1.178 1.289 0.00001 1.189 0.00024 1.239 0.00495
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A p p e n d ix  6
Concentration (ng/ml) of isometamidium in individual sera of treated cattle at North
Nyamphande. ND: not detected. NS : No sample.
Animal No -1 4  
days
+ 14 
days
28 days 42 days 56 days 70 days 84 days
863 ND 1.504 0.921 ND ND 0.296 ND
866 0.276 2.503 0.998 0.394 ND ND ND
864 0.422 1.627 1.111 ND ND ND ND
869 0.354 1.45 0.733 0.261 ND ND ND
886 0.388 4.19 1.661 NS ND ND 0.248
884 ND 1.252 1.381 NS 0.336 0.221 0.377
883 ND 2.156 0.841 0.36 ND NS ND
881 ND 1.47 0.947 0.445 0.228 NS NS
610 0.236 1.71 0.499 NS ND ND NS
612 ND 2.019 0.946 0.496 0.276 ND NS
426 ND 0.917 0.643 0.284 0.448 ND ND
428 0.413 2.638 1.468 0.388 0.306 ND NS
429 ND 2.066 NS NS ND ND 0.338
871 0.221 1.828 1.284 0.574 0.204 0.421 0.248
870 ND 3.066 0.834 ND 0.28 ND ND
247 ND 0.942 0.788 0.516 0.226 ND ND
246 0.205 1.44 0.547 NS 0.204 0.232 0.298
872 ND 1.154 0.708 0.777 0.519 10.957 ND
860 0.208 2.602 1.256 0.918 NS NS NS
862 ND 3.034 NS 0.618 NS 0.45 ND
614 ND 4.422 1.676 1.584 1.812 0.376 0.308
880 0.233 1.981 0.693 1.901 0.338 0.404 0.298
617 ND 1.754 1.254 NS NS NS 0.251
649 ND 0.46 0.196 0.36 NS NS NS
648 0.271 2.495 1.262 0.379 ND ND ND
643 ND 2.146 0.784 0.292 ND 0.28 ND
646 ND 2.47 1.046 0.552 0.34 0.222 0.246
645 ND 1.399 0.516 ND NS NS 0.212
641 ND 3.505 1.984 0.671 0.304 ND ND
623 ND 1.94 0.991 0.442 NS ND NS
625 ND 2.02 0.754 ND NS 1.288 0.562
628 1.323 1.852 0.452 0.973 0.501 0.75 1.292
632 ND 1.661 0.722 0.375 0.284 0.202 ND
622 NS NS 0.554 ND 0.447 0.263 0.236
889 ND 2.336 0.676 NS 0.227 ND ND
Average 0.379 2.059 0.943 0.619 0.404 0.416 0.358
SD 0.308 0.863 0.396 0.405 0.365 0.301 0.287
Median 0.274 1.961 0.841 0.496 0.305 0.296 0.275
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A p p e n d ix  7
Concentration (ng/ml) of homidium in the sera of individual cattle treated with SRD-
homidium at Chipopela. ND: not detected. NS: No sample.
Animal Month Month Month Month Month Month Month6
No 0 1 2 3 4 5
207 ND 0.161 1.116 0.205 0.373 0.225 ND
208 ND 0.388 0.945 0.413 0.373 0.225 ND
210 ND 0.296 0.543 0.4 0.356 NS NS
519 ND NS NS 0.538 0.472 0.313 NS
532 ND 0.362 0.442 0.24 NS NS NS
533 0.202 0.395 1.166 0.444 0.24 0.335 NS
534 0.504 0.371 0.769 0.4 0.411 0.257 ND
535 ND 0.273 0.476 0.226 0.187 ND ND
538 ND 0.29 0.975 NS 0.313 ND ND
539 0.214 NS 0.898 0.244 ND ND ND
542 0.267 0.359 NS 0.411 0.232 ND ND
543 0.652 0.573 0.727 0.301 0.303 0.205 NS
676 1.002 0.777 NS NS NS NS NS
677 ND 0.486 NS 0.667 0.317 NS NS
AVG 0.264 0.394 0.806 0.374 0.3 0.196 ND
STD 0.276 0.153 0.245 0.133 0.091 0.097
0.54 0.547 1.051 0.507 0.391 0.294
MED 0.129 0.366 0.834 0.4 0.308 0.205
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A p p e n d ix  8
Concentration (ng/ml) of homidium in the sera of individual cattle treated with
homidium intramuscularly at Chipopela. ND: not detected. NS: No sample.
Animal Month Month Month Month Month Month Month
No 0 1 2 3 4 5 6
200 0.206 0.398 0.211 ND ND ND ND
206 ND 0.307 ND ND ND ND ND
209 ND 0.24 ND ND ND ND ND
212 ND NS ND ND ND ND ND
214 ND 0.252 NS ND ND ND ND
216 ND ND 0.225 ND ND ND ND
217 ND 0.246 ND ND ND NS NS
219 ND 0.22 0.209 NS 0.355 0.281 ND
222 ND 0.243 ND ND ND NS NS
225 0.631 0.507 0.238 ND NS NS NS
231 0.322 0.211 ND 0.216 0.214 0.418 ND
236 0.369 NS 0.201 ND NS NS NS
239 0.216 0.371 0.224 NS NS NS NS
241 ND 249 ND ND ND NS NS
673 ND 1.056 0.453 NS NS NS NS
690 ND ND ND ND ND NS NS
691 0.237 0.28 NS ND NS NS NS
692 ND 0.254 ND ND NS NS NS
697 ND 0.309 ND ND NS NS NS
AVG 0.212 0.312 ND ND ND ND ND
STD 0.132 0.211
0.344 0.524
MED 0.191 0.252
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A p p e n d ix  9
Concentration (ng/ml) of isometamidium in the sera of individual cattle treated with 
isometamidium intramuscularly at Chipopela.
Animal Month Month Month Month Month Month Month
No 0 1 2 3 4 5 6
201 0.32 NS 1.36 NS 0.2 ND ND
220 0.39 NS 0.52 NS 0.2 ND ND
221 ND NS 0.69 NS 0.2 0.385 ND
223 1.81 0.82 0.25 ND ND NS NS
229 ND 0.94 0.16 ND 0.7 NS NS
245 ND 0.56 0.35 ND NS NS NS
247 0.28 NS 0.6 NS 0.2 NS ND
248 ND NS 0.8 NS 0.2 ND ND
249 0.42 1.41 0.33 0.24 0.6 NS NS
530 ND 0.87 0.3 ND 0.2 ND ND
531 ND NS 1.19 0.37 0.3 ND ND
536 ND 1.35 0.62 0.26 0.2 0.284 0.217
537 ND 1.43 0.56 0.26 NS ND NS
540 ND 0.51 0.21 ND 0.3 ND ND
545 ND NS NS 0.54 NS 0.227 NS
546 0.59 NS 0.79 0.33 ND ND ND
547 0.24 2.37 0.63 0.27 NS ND ND
548 0.69 1.12 0.36 ND NS NS ND
549 ND NS 0.6 0.22 0.2 ND ND
674 ND 2.27 0.69 0.25 ND NS NS
AVG 0.35 1.24 0.58 0.24 0.4 0.182 ND
STD 0.41 0.59 0.31 0.11 0.4 0.074
0.75 1.83 0.89 0.35 0.7 0.255
MED 0.18 1.12 0.6 0.24 0.2 0.151
